Published: December 3, 2018

Introduction {#sec1}
============

The winged-helix, forkhead transcription factor (TF) FoxD3 is an important stem cell factor that functions reiteratively during development. At early stages of development, it is thought to maintain pluripotency of epiblast cells. In embryonic stem (ES) cells, its loss leads to premature differentiation into mesendodermal lineages while ectodermal lineage markers are reduced ([@bib47]). Later, FoxD3 plays a critical role in the specification and subsequent differentiation of the neural crest (NC), a remarkable transitory and multipotent embryonic cell population. NC cells are specified at the border of the forming central nervous system (neural plate border, NPB), but then undergo an epithelial to mesenchymal transition (EMT) to delaminate from the neural tube, migrating into the periphery where they give rise to diverse derivatives such as peripheral ganglia, craniofacial skeleton, and pigmentation of the skin ([@bib67]). Although individual neural crest cells are multipotent ([@bib5], [@bib10]), it has been a matter of debate whether the NC population as a whole is homogeneous or a heterogeneous mixture of cells specified toward a particular fate ([@bib23], [@bib38], [@bib54]).

The molecular mechanisms by which FoxD3 influences ES cell development *in vitro* have been extensively studied. During the transition from naive to primed pluripotency cells, FoxD3 represses enhancers by recruiting H3K4 demethylase, Lsd1, resulting in a decrease of active enhancer marks and an increase in inactive enhancer marks ([@bib64]). During the subsequent pluripotent to epiblast cell transition, FoxD3 primes enhancers by co-recruiting nucleosome remodelling and deacetylase complex members Brg1 and histone deacetylases 1/2 (HDAC1/2). As a result, different subsets of enhancers get fully activated or are kept repressed during differentiation, depending on the effects mediated by HDAC1/2 removal or retention ([@bib37]). These studies led to the realization that FoxD3-mediated gene regulation in ES cells may function via modulation of associated enhancers.

In contrast to ES cells, the molecular mechanisms through which neural crest cells transition from pluripotent cells to fate restricted cells in the embryo and the role of FoxD3 therein remain poorly understood. A neural crest gene regulatory network (GRN) that describes the genes expressed during NC ontogeny and their epistatic relationships has been proposed ([@bib67]). Within this framework, FoxD3 is known to act downstream of NPB genes and upstream of factors mediating EMT ([@bib8], [@bib70]). In the zebrafish embryo, *foxd3* is one of the earliest zygotically expressed genes ([@bib41]), first detected during epiboly in the dorsal mesendoderm and ectoderm ([@bib81]) and later in the NPB, tailbud mesoderm, and floor plate ([@bib55]). A second phase of *foxd3* expression occurs in premigratory neural crest cells within the neural folds at all axial levels. Even later, *foxd3* becomes restricted to a subset of migrating cranial neural crest cells and is downregulated in the trunk crest, reappearing in neural crest-derived peripheral glia and other tissues such as the somites ([@bib22], [@bib31]).

Here, we tackle the molecular mechanisms by which *foxd3* influences neural crest development by taking advantage of wild-type and mutant zebrafish *foxd3* lines to characterize the transcriptional and epigenetic landscape of *foxd3*-expressing cells *in vivo*. First, using single-cell RNA sequencing, we demonstrate that *foxd3*-expressing cells display a distinct and homogeneous molecular signature in a stage-specific manner. Intriguingly, we observed a decoupling of the different strategies employed by foxd3 to regulate gene expression over the course of neural crest ontogeny. Contrasting with its previously defined role as a transcriptional repressor, early knockout *foxd3*, in the premigratory crest, resulted in global downregulation of neural crest genes, favoring the idea that foxd3 acts as a pioneer factor during early stages of neural crest development. This was shown by comprehensively analyzing the effects of foxd3 depletion on chromatin accessibility, histone modifications, and nucleosome positioning, as well as by generating in-depth stage-specific foxd3 binding maps using our newly developed biotin chromatin immunoprecipitation sequencing (ChIP-seq) method. At later stages, foxd3 assumes its known role as a transcriptional repressor. Biotin ChIP-seq confirms the direct association of foxd3 with a number of genes, both downregulated and upregulated in the foxd3 mutant, exemplifying its bimodal function in NC gene regulation. By exploring the underlying foxd3 DNA binding codes across different stages of NC development (early-activating and late-repressing stages), we show that these two contrasting foxd3 activities are likely to be achieved by engaging differential co-partners. This in turn possibly leads to the recruitment of different chromatin remodeling complexes, such as Brg1 or PRC1 members, that mediate chromatin priming and compaction, respectively. In summary, we demonstrate that foxd3 drives several independent chromatin-organizing mechanisms, switching from activator to repressor roles to orchestrate multiple regulatory programs during NC formation, starting with priming early NC specification to regulating essential signaling pathways, maintaining multipotency by controlling stem cell programs, and preventing premature migration and differentiation into neuronal NC derivatives.

Results {#sec2}
=======

Single-Cell RNA-Seq Identifies Distinctive Transcriptional Signatures between foxd3+ Stem Cells and foxd3+ NC Cells {#sec2.1}
-------------------------------------------------------------------------------------------------------------------

In this study, we examined foxd3 roles throughout premigratory and migratory NC ontology in zebrafish embryos ([Figure 1](#fig1){ref-type="fig"}A). We first looked at 75% epiboly stage embryos during which gastrulation takes place, forming the embryonic shield and hypoblast. We then looked at premigratory NC stages, which occur during the zebrafish segmentation period and when NC gets induced and later specified at the NPB 1--2 and 5--6 somite stages (ss), respectively. Finally, we examined a migratory NC stage (14--16ss).Figure 1Transcriptome Characterization of *foxd3*-Expressing NC(A) Zebrafish embryo stages examined in this study (hpf -- hours post fertilization). 75% epiboly---a gastrulation stage during which embryonic shield and hypoblast are formed. 1--2 and 5--6 somite stages---induced and specified premigratory neural crest (NC), respectively. 14--16ss -- migratory NC. Foxd3 expression is labeled in green.(B) Experimental pipeline for obtaining *foxd3*-expressing cells and performing single-cell RNA-seq (scRNA-seq). The genetrap zebrafish line, *Gt(foxd3-citrine)*^*ct110*^, expressing foxd3-Citrine fusion is outcrossed to wild-type resulting in fluorescent signal in endogenous *foxd3*+ cells, enabling their isolation by FACS. 5--6ss Citrine-positive NC cells are collected into individual wells of the 96-well plate and processed for smartseq2-based scRNA-seq. Total of 94 cells was sorted with two empty, External RNA Controls Consortium (ERCC)-only wells left as controls.(C) Heatmaps illustrating the hierarchical clustering of *foxd3+* single cells at 75% epiboly (200 cells) and 5--6ss (93 cells) and showing transcriptional levels (depicted in Log2 RPKM) of selected NC and stem cell genes. NC cells that express negligent levels of *bona fide* NC specifiers (*zic2b*, *tfap2a*, *sox10*, *twist1b*, *ets1*, or *pax3a*) but high levels of *lratb*, *cxcr4b*, and *ved*, as well as other markers of stemness (*snai1a*, *vent*, *vox*, and *cx43.4*), possibly representing pluripotent non-specified NC progenitors maintained in premigratory NC (boxed and labeled in red).(D) tSNE plots for selected stem cell (*sox2*, *pou2f1*, *vent*) and NC genes (*snai1a*, *sox5*, *tfap2a*, *sox10*) indicate individual epiblast, and NC cells do not reveal cell subpopulations. Clustering of 5--6ss NC cells identifies a small group of cells that appear to be pluripotent non-specified NC progenitors. See [Figure S1](#mmc1){ref-type="supplementary-material"} for scRNA-seq quality control (QC) and more details.

As a first step in characterizing the global developmental functions of foxd3, we examined *foxd3*-positive stem and NC cells at a single-cell level, to ascertain whether these seemingly different cell populations were non-heterogeneous. There have been debates in the literature regarding whether the premigratory neural crest is a homogeneous or heterogeneous cell population ([@bib23], [@bib38], [@bib54]). We used a gene trap line, *Gt(foxd3-citrine)*^*ct110*^ ([@bib25]), which drives the expression of foxd3-Citrine fusion, yielding a fluorescent signal in endogenous *foxd3+* cells. This line enabled us to carry out RNA sequencing (RNA-seq) on single *foxd3*-expressing NC cells (single-cell RNA-seq \[scRNA-seq\]) isolated from the developing zebrafish embryos by fluorescence-activated cell sorting (FACS) ([Figure 1](#fig1){ref-type="fig"}B). Metrics show that our libraries are of excellent quality (high complexity, a high number of uniquely mapped sequencing reads, and up to ∼5,500 transcripts detected per cell; [Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B). We performed t-distributed stochastic neighbor embedding (tSNE) and principal-component analyses (PCAs) of single-cell transcriptomes at 5--6ss, based on either all 5,243 or the top 500 most divergent genes ([Figures S1](#mmc1){ref-type="supplementary-material"}C and S1D). Surprisingly, we failed to identify multiple NC-specific subpopulations but instead singled out a small population of NC cells which expressed extremely low levels of *bona fide* NC specifiers (*zic2b*, *tfap2a*, *sox10*, *twist1b*, *ets1*, or *pax3a*) and lower levels of *foxd3* itself. However, these cells expressed high levels of *lratb*, *cxcr4b*, and *ved*, as well as other markers of multipotent progenitors (*snai1a*, *vent*, *vox*, and *cx43.4*; [Figure 1](#fig1){ref-type="fig"}C, outlined in red), suggesting that they may represent pluripotent non-specified NC progenitors maintained in premigratory NC.

In addition, to identify potential differences between the *foxd3*-positive stem and NC cells, we compared the transcriptional *foxd3*+ single-cell signatures at 50% epiboly (5.3 hours post fertilization \[hpf\]) ([@bib66]) and 5--6ss (this study) ([Figures 1](#fig1){ref-type="fig"}C, 1D, [S1](#mmc1){ref-type="supplementary-material"}E, and S1F). tSNE plots comparing expression of core NC and stem cell genes in single *foxd3+* cells show that, at both stages, nearly all *foxd3+* cells expressed the pluripotency factor *cx43.4* and NPB specifiers *id1* and *zic2b* at high levels, while more than 50% of cells expressed *pou2f1b*, *zic3*, and id3 ([Figures 1](#fig1){ref-type="fig"}C and 1D). Interestingly, however, the expression of core pluripotency factors was different at the two stages examined. The majority of *foxd3+* single cells at 50% epiboly expressed *Oct4* orthologs (*pou5f3*, *pou2f1b*), *SoxB* ortholog (*sox3*), *nanog*, and *vox* (reminiscent of *Xenopus XOct*, *Xsox2*, and *XVent*) ([@bib12]). In contrast, 5--6ss single *foxd3+* cells did not express *nanog*, and only a few cells expressed *sox3* or *pou5f3* at low levels ([Figures 1](#fig1){ref-type="fig"}C and [S1](#mmc1){ref-type="supplementary-material"}E), while the greater portion of cells expressed paralogous factors *sox2*, *pou2f1b*, *vent*, and *vox* ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}E). Furthermore, *foxd3+* gastrula progenitors expressed a different complement of orthologs of EMT factors compared to premigratory NC, with *zeb1a*, *snai1a*, and *snai2* present at 50% epiboly, but poorly expressed in most 5--6ss *foxd3+* NC cells, which favored *zeb1b*/*2a* and *snai1b* ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}E). NC specifiers (*sox5*, *sox10*, *twist1b*, *pax3a*) were expressed at high levels in almost all 5--6ss *foxd3+* NC cells but were absent from the majority of 50% epiboly *foxd3+* cells, where early NC specifiers (*snai1b*, *sox9b*, *tfap2a*, *ets1*, *id2a*) were expressed more pervasively ([Figures 1](#fig1){ref-type="fig"}C, 1D, and [S1](#mmc1){ref-type="supplementary-material"}F). In *Xenopus*, it has been suggested that neural crest cells may retain blastula-stage competence ([@bib12]). We found that orthologs of *Xenopus* genes were indeed expressed in the 50% epiboly *foxd3+* cells in zebrafish ([Figure 1](#fig1){ref-type="fig"}C). However, as described above, our data revealed that 5--6ss *foxd3*+ cells do not express the same but rather paralogous pluripotency factors to those found in the epiblast. This suggests a possible redeployment of a paralogous GRN rather than maintenance of the epiblast GRN in the newly specified neural crest, in agreement with the recent single-cell-based analysis performed in both frog and fish ([@bib9]), and thus challenging the proposition that NC cells are residual blastula cells ([@bib12]).

Taken together, the results show that both *foxd3*+ epiblast and *foxd3*+ premigratory NC cell populations are non-heterogeneous, as well as distinctive from one another.

Knockout of foxd3 Leads to Downregulation of NC Specifier Genes at Premigratory NC Stages and Upregulation of NC Differentiation Genes at Migratory NC Stages {#sec2.2}
-------------------------------------------------------------------------------------------------------------------------------------------------------------

We next inquired how foxd3 depletion affects NC progenitor cells on a transcriptional level using two zebrafish transgenic lines *Gt(foxd3-mCherry)*^*ct110R*^ and *Gt(foxd3-Citrine)*^*ct110*^ ([Figures 2](#fig2){ref-type="fig"}A and 2B) in which the fluorescent reporter proteins interrupt the DNA binding domain, creating mutant fluorescent *foxd3* alleles ([@bib25]). These lines were crossed, and dissociated embryonic cells obtained from corresponding clutches were fluorescence activated cell (FAC)-sorted to isolate Citrine only expressing *foxd3+* cells (C) as a control and *foxd3*-mutant cells expressing both fluorophores (Citrine and Cherry; CC) ([Figures 2](#fig2){ref-type="fig"}A and 2B). PCA and scatterplots of normalized read counts comparing RNA-seq biological replicates show a high level of reproducibility in our experiments ([Figure S2](#mmc1){ref-type="supplementary-material"}). *De novo* assembly and analysis of the *foxd3*-mutant transcriptomes revealed the presence of truncated foxd3 fluorescent fusion transcripts ([Figure S3](#mmc1){ref-type="supplementary-material"}A), encoding only 93 N-terminal amino acids, as shown previously ([@bib25]). The truncated N-terminal foxd3 variants are non-functional ([@bib87]), whereas dominant negative activity is associated with the C terminus regions ([@bib39], [@bib93]). Utilizing these lines, we investigated transcriptional changes in the absence of the functional foxd3 protein at three key stages of neural crest ontogeny (75% epiboly, 5--6ss, and 14--16ss) ([Figure 2](#fig2){ref-type="fig"}A).Figure 2Transcriptional Profiling of *foxd3* Mutant NC(A) Experimental strategy for obtaining *foxd3*-mutant (yellow) and *foxd3*-control (green) NC cells. Mutant (Citrine/Cherry; CC) and control (Citrine only; C) NC cells were isolated by FACS from crosses of heterozygote fluorescent *foxd3* transgenic fish, *foxd3-mCherry and foxd3-Citrine* at three stages---75% epiboly, 5--6ss, and 14ss.(B) Lateral view of a *foxd3*-mutant embryo expressing both Citrine and mCherry instead of foxd3 in premigratory NC.(C and D) (C) Bar plot comparing numbers of differentially expressed genes in *foxd3*-mutant and control NC and (D) violin plots comparing fold-change differences.(E and F) Venn diagrams comparing upregulated (E) and downregulated (F) genes in *foxd3*-mutant cells.(G) Heatmap showing fold change in expression of known NC genes between *foxd3*-mutant and control cells at 75% epiboly, 5--6ss, and 14ss. Genes are grouped to reflect NC-GRN structure.(H) Bubble plot summarizing enrichment and ps (Benjamini-Hochberg corrected) for the most significant biological process GO terms associated to differentially expressed genes.(I) In situ hybridization of 3--6ss zebrafish embryos (dorsal view) showing decrease or loss in expression of NC specifier genes in *foxd3*-mutants.(J) Bar plot representing fold change in expression of NC factors showing that paralogs are differentially regulated by foxd3.

At 75% epiboly, differential expression analysis between *foxd3*-mutant (CC) and control samples (C) yielded comparable numbers of upregulated and downregulated genes. In contrast at 5--6ss and 14--16ss, a larger number of putatively repressed foxd3 targets (or upregulated genes) was observed ([Figures 2](#fig2){ref-type="fig"}C and 2D), suggesting a possible change between activator and repressor roles of foxd3 during NC ontogeny. Sets of upregulated and downregulated genes were distinct at different stages, with some level of overlap between 5--6ss and 14--16ss, in particular among the genes de-repressed in *foxd3* mutants ([Figures 2](#fig2){ref-type="fig"}E and 2F).

FoxD3 is required for maintenance of the multipotent NC progenitor pool and, at later stages, for control of distinct NC lineage decisions, mostly by repressing mesenchymal and promoting neuronal derivatives ([@bib19], [@bib35], [@bib46], [@bib51], [@bib52], [@bib74], [@bib76]). Examination of gene ontology (GO) terms overrepresented in differentially regulated genes indicated that at 75% epiboly, foxd3 appears to repress cell metabolism pathways, in particular ribosome biogenesis, RNA processing, and translation genes, as well as to negatively control genes involved in progenitor adhesion and migration (e.g., *nrp2a*, *nrp1b*, *slit1a*; ^∗^p \< 0.05; [Figures 2](#fig2){ref-type="fig"}G and 2H), while at the same time priming genes involved in tissue-specific programs (*gata2a*, *gata5*, *ets1*, *six1a*/*b*, *tfap2a*/*c*, etc.) ([Figures 2](#fig2){ref-type="fig"}G and 2H). Strikingly at 5--6ss, we found *foxd3*-mutant cells (CC) downregulated a large proportion of known NC genes distributed across all defined NC-GRN modules (^∗∗^p \< 0.01; [Figures 2](#fig2){ref-type="fig"}G and 2H), many of which were *bona fide* NC transcription factors (∼40%) and signaling or cell junction and adhesion molecules (∼25%) ([Figures 2](#fig2){ref-type="fig"}G and [S3](#mmc1){ref-type="supplementary-material"}B). Some factors previously reported to act upstream of *foxd3*, such as *prdm1* and *tfap2a/c* ([@bib43], [@bib62], [@bib67]), were downregulated ([Figure 2](#fig2){ref-type="fig"}G), challenging proposed epistatic relationships within the NC-GRN. Statistical overrepresentation of the entire set of genes downregulated at 5--6ss yielded highly significant association with neural crest and stem cell development GO terms as well as terms linked to onset of EMT, cell adhesion changes, and NC cell migration (Bonferroni; ^∗∗^p \< 0.01; [Figure 2](#fig2){ref-type="fig"}H). Interestingly, enriched terms also linked to NC derivative fates (pigment cells, cranial skeletal development, and autonomic and enteric nervous system). However, this enrichment was correlated to the defect in expression of the core NC TFs (*pax3a*, *sox9b*, *sox10*, *tfap2a*, etc.) that act both in NC specification and later in NC differentiation rather than to the loss of NC downstream differentiation markers proper, which were unaffected at premigratory stage (5--6ss) ([Figure 2](#fig2){ref-type="fig"}G). Downregulation of NC specifiers was confirmed by in situ hybridization ([Figure 2](#fig2){ref-type="fig"}I).

Analysis of *foxd3* mutant cells (CC) at migratory NC stages (14--16ss) showed dysregulation of NPB and derivative markers ([Figure 2](#fig2){ref-type="fig"}G). Surprisingly, in migrating *foxd3*-mutant NC, we observed an untimely upregulation of markers of ectomesenchymal derivatives (*lmx1ba/b*, *bmp5/6*, *col2a1b*) and neuronal lineages (*delta b/d*, *robo4*, *slit1a/b*, *slit2*/*3*), but only partially of melanophore, xanthophore (*isl1*, *kita1*, *pmela*/*b*, *tyrp1b*, *ascl1a*), and glial lineages (*gfap*, *olig2*/*4*, *gfra1b*, *myt1a*/*b*, *plp1*, *slc1a3b*, *bhlhe23*), which normally would be expressed much later or not expressed in *foxd3+* NC derivatives ([Figure 2](#fig2){ref-type="fig"}G). Notably, two other characterized zebrafish *foxd3* mutants, mother superior (*mos*) ([@bib51]) and sympathetic (*sym1*) ([@bib74]), showed cranio-facial defects at later stages of development (∼3 dpf \[days post fertilisation\]) affecting branchial arches while *sym1* mutants were also lacking sympathetic neurons. Our observed mis-expression of differential markers at 14--16ss that were expected to be expressed at later stages (∼20ss) suggests a likely dysregulation of differentiation of daughter cell types at stages prior to that at which the phenotype is observed.

Several derivative and ectomesenchymal markers (*col2a1a*/*b*, *lmx1bb*/*b*) and cell surface signaling molecules (*epha4a*, *slit2*/*3*, *robo4*), were already de-repressed at the premigratory stage ([Figure 2](#fig2){ref-type="fig"}G), in line with a role of foxd3 in preventing premature differentiation into NC derivatives. Statistical overrepresentation tests associated the upregulated gene sets to multiple GO terms reflecting biological processes essential for NC migration (cell migration and adhesion), suggesting a possible role of foxd3 in active repression mesenchymal and migrating programs at this stage ([Figures 2](#fig2){ref-type="fig"}G and 2H). Interestingly, a number of derivative markers associated with late NC differentiation (neurogenesis, axonogenesis), not expressed above background (\> 1FPKM) in *foxd3+* control cells (C) at this stage, were upregulated (de-repressed) in *foxd3*-mutant cells (CC), suggesting a continuous repressive role of foxd3, possibly ensuring commitment to specific NC lineages.

To assess whether the foxd3 mutant cells retain their NC identity, we performed comparative differential expression analysis of *foxd3*-control (C) and *foxd3*-mutant (CC) cells versus the corresponding foxd3-negative embryonic cells. Examination of their transcriptional signature shows that *foxd3*-mutant cells retain a mesenchymal NC-like phenotype and have distinct signatures from the other cells in their environment ([Figure S3](#mmc1){ref-type="supplementary-material"}C). This is consistent with extensive phenotypic analysis of *foxd3*-mutants demonstrating that they exhibit defects in formation of the full complement on NC derivatives ([@bib25]).

Interestingly, several paralogs belonging to the same gene family were differentially regulated in the mutant cells. For instance, key NC factors (*snai1b*, *twist1b*, etc.) were downregulated, while *snai2* and *twist2* were upregulated ([Figure 2](#fig2){ref-type="fig"}J), offering a possible mechanism for rescue of *foxd3* transcriptional phenotype by paralogous genes ([@bib49]). Additionally, several Fox transcription factors were upregulated in *foxd3* mutants, which suggests a different, upstream compensating mechanism by different Fox family members.

Altogether, these results show that foxd3 may play different regulatory roles depending on the temporal context. Importantly, in the absence of a functional foxd3 protein, much of the NC specification module is absent at 5--6ss. We also find unexpected other Fox proteins and alternative NC factor upregulation that suggests a potential compensation in the mutant and explains a partial rescue of NC specification by early delaminating NC stages ([Figures 2](#fig2){ref-type="fig"}J and [S3](#mmc1){ref-type="supplementary-material"}D). While genes associated with NC and stem cell processes are downregulated in the mutant premigratory NC, genes governing migration and differentiation are upregulated at migratory stages ([Figure 2](#fig2){ref-type="fig"}H), suggesting that foxd3 switches from an activator to a repressor of NC programs.

Biotin-ChIP Confirms Direct Bimodal Action of foxd3 on the NC Gene Regulation {#sec2.3}
-----------------------------------------------------------------------------

To further investigate the apparent bimodal function of foxd3 in gene regulation throughout NC ontogeny, we interrogated the genome-wide dynamics of direct foxd3 binding from early steps of NC induction (75% epiboly, 1--2ss) and specification (5--6ss) to migratory NC stages (14ss). To this end, we used our recently developed binary biotagging approach ([@bib78]), enabling specific biotinylation of target proteins *in vivo* for subsequent use in biochemical procedures ([Figure 3](#fig3){ref-type="fig"}A). The effector transgenic zebrafish line*, TgBAC(foxd3-Avi-2A-Citrine)*^*ox161*^, expressing Avi-tagged foxd3 protein in an endogenous fashion ([Figure 3](#fig3){ref-type="fig"}B), was crossed to the ubiquitous BirA driver, *Tg(ubiq:NLS-BirA-2A-Cherry)*^*ox114*^, expressing the biotin ligase, BirA, targeted to the nucleus ([Figure 3](#fig3){ref-type="fig"}A). The resulting progeny was collected for biotin ChIP-seq ([Figure 3](#fig3){ref-type="fig"}C), with BirA-only expressing embryos used as control.Figure 3Biotin-ChIP Analysis Supports a Direct Bi-modal foxd3 Regulatory Action on NC Gene Expression(A) Experimental strategy for biotagging foxd3 protein *in vivo*. Zebrafish transgenics expressing Avi-tagged *foxd3* and ubiquitous NLS-BirA are crossed to obtain embryos expressing biotinylated foxd3 for use in biotin ChIP-seq.(B) Lateral view of the embryo issued from crosses of *TgBAC(foxd3-Avi-2A-Citrine)*^*ox161*^ and *Gt(foxd3-mCherry)*^*ct110R*^ shows overlap of Citrine and Cherry reporters. Scale bars correspond to 100 μm.(C) Genome browser screenshot showing mapped foxd3-biotin-ChIP-seq at 75% epiboly (in blue), 1--2ss (in pink), 5--6ss (in light green) and 14ss (in dark green) developmental zebrafish stages within the *foxd3* regulatory locus. BirA-only ChIP-seq control at 5--6ss is shown in purple (top track). Positions of called peaks are indicated as vertical lines underneath each biotin-foxd3 ChIP track. The bottom track black boxes display identified *cis*-regulatory elements of the *foxd3* gene.(D) Volcano plot highlighting that most NC specifiers are downregulated in *foxd3*-mutant NC at 5--6ss. On the left side (downregulated genes), genes directly bound by foxd3 at 1--2ss are marked in bold. On the right side (upregulated genes), genes that are still upregulated at 14ss and are directly bound by foxd3 at 5--6ss and 14ss are marked in bold.(E) Heatmap displaying top 50 most upregulated genes, based on log~2~-fold change of differential gene expression, out of total 223 genes, at 14ss in *foxd3* mutant (CC) NC that were found to be occupied by foxd3 at 1, 2, 3, or 4 associated *cis*-regulatory elements at 5--6ss and 14ss.(F) Bar plot showing GO terms significantly enriched (^∗∗^p \< 0.01) to downregulated genes at 5--6ss in blue and upregulated genes at 14ss in red in *foxd3*-mutant embryos that were bound by foxd3 at 1--2ss and at 5--6ss/14ss, respectively.

Biotin ChIP-seq revealed 624 foxd3-bound regions at 75% epiboly, 531 at 1--2ss NC, 2,955 at 5--6ss NC and 658 at 14ss NC, with only 89 non-specific peaks identified in the BirA-only controls. The substantial increase in foxd3-occupied genomic loci at 5--6ss followed by a drop in the peak number at 14ss suggests that the 5--6 somite stage represents a highly dynamic interface stage encompassing both activating and repressive modes of foxd3 action.

We next sought to distinguish genes that are either directly activated or repressed by foxd3. To this end, we annotated each NC foxd3-biotin ChIP-seq peak to the nearest expressed gene at the corresponding or later stage. We found that 14.3% of genes downregulated in the 5--6ss *foxd3*-mutant NC ([Figure 3](#fig3){ref-type="fig"}D) and 30.8% of genes upregulated in the 14ss *foxd3-*mutant NC were normally directly bound by foxd3. Notably, 61 out of 223 direct foxd3 target genes (at 5--6ss and 14ss) were found upregulated in *foxd3* mutants starting from 5--6ss ([Figure 3](#fig3){ref-type="fig"}D). This further supports our hypothesis that foxd3-mediated activation of later NC factors and foxd3 repression of those no longer used co-occur at the premigratory NC stage.

Statistical overrepresentation of foxd3-primed, directly controlled genes, downregulated in *foxd3*-mutant at 5--6ss ([Figure 3](#fig3){ref-type="fig"}D) revealed a significant association with neural crest, stem cell, and mesenchymal cell development, NC cell migration, and regulation of neurogenesis (^∗∗^p \< 0.01; [Figure 3](#fig3){ref-type="fig"}F). Important genes in NC development, such as *pax3a*, *tfap2a*, *nrp2a*, and *foxd3* itself, appeared to be positively regulated by the upstream action of foxd3 at early premigratory NC stages. Similarly, expression of transcription factors *id2a* and *gata3*, a signaling molecule *wnt4a* and a cytokine *mdkb* (all implicated in NC neuronal lineages), also appeared to be activated by foxd3 ([Figure 3](#fig3){ref-type="fig"}D). Conversely, by 14ss stage, foxd3-facilitated gene repression was directed at various genes involved in cell fate commitment, including *olig2*, *tfap2c*, and *hey2*, wnt signaling genes (e.g., *wnt3*), and neuronal differentiation (e.g., *slit2/3*, *neurod4*, *gli2b*, *otx2*, and *efna1b*; [Figures 3](#fig3){ref-type="fig"}E and 3F).

Cumulatively, our foxd3 biotin ChIP-seq data in premigratory and migratory NC argue for direct activation of a large portion of NC specification genes, followed by direct repression of cell differentiation genes, particularly to prevent premature differentiation into neuronal lineages.

foxd3 Affects Chromatin Accessibility of Distal *cis*-Regulatory Elements {#sec2.4}
-------------------------------------------------------------------------

The counter-intuitive finding that a large number of NC specification factors ([Figures 2](#fig2){ref-type="fig"}G and [3](#fig3){ref-type="fig"}D) were downregulated in *foxd3*-mutant at 5--6ss raises the intriguing possibility that, much like FoxA1/A2 factors during endodermal specification ([@bib27]), FoxD3 may act as a pioneer factor during NC specification. Therefore, in addition to its described role as a transcriptional repressor ([@bib85], [@bib86]), FoxD3 may modulate the local epigenetic state of multiple *cis*-regulatory elements and thus positively control NC genes. To assess chromatin accessibility status in *foxd3*-mutant NC cells, we carried out cell-type specific assay for transposase-accessible chromatin using sequencing (ATAC-seq) at different stages of NC formation on either FAC-sorted *foxd3*-expressing (C) and *foxd3*-mutant NC cells (CC) (75% epiboly and 5--6ss) or on dissected *foxd3*-mutant and control anterior embryonic cells at 1--2ss. In addition, we used our previously published 16ss *sox10*-specific ATAC-seq ([@bib78]), containing an extensive cohort of open *cis*-regulatory elements in migratory NC.

We recovered a constant number of open chromatin regions (ATAC-seq peaks) at all early stages with a similar genomic distribution as distal (intronic, intergenic) or proximal (promoter). The dramatic increase in the total number of open elements in late migratory and differentiating NC cells was entirely accounted for by novel distal non-promoter elements ([Figure 4](#fig4){ref-type="fig"}A). The foxd3 depletion did not affect the distribution of peaks according to genomic annotation (p = 0.8743 and 0.614 for epiboly and 5--6ss, respectively), and over 60% of total peaks observed in *sox10*-specific differentiated cells were already opened at earlier stages ([Figures 4](#fig4){ref-type="fig"}B and 4E). To verify whether the open chromatin state of promoters and distal *cis*-regulatory elements correlates with gene expression, we analyzed the transcription levels of the closest associated genes. We noted a bimodal distribution of gene expression levels associated with putative enhancer elements at all stages but with putative promoters only at epiboly. Unimodal distributions after epiboly for genes associated with putative promoters indicated an onset of the *cis*-regulatory role for foxd3 at 5--6ss ([Figure 4](#fig4){ref-type="fig"}C). Moreover, while at 75% epiboly, the difference in number of unique peaks in control (C) and cells is negligible (21% versus 19%), the number of peaks in control cells at 5--6ss is almost 2-fold of that in mutants (33% versus 17%) ([Figure 4](#fig4){ref-type="fig"}D).Figure 4Epigenomic Profiling of Chromatin Accessibility in *foxd3* Mutant NC across Developmental Time(A and B) (A) Stacked bar plots depicting genomic annotation of ATAC-seq peaks across stages analyzed (75% epiboly; bud stage; 5--6ss and 14--16ss) and (B) quantification of open elements at earlier stages as a proportion of accessible elements detected in migrating/differentiating NC.(C) Violin plots correlating putative promoter and *cis*-regulatory elements with gene expression levels. Bimodal distribution of gene expression is associated with putative enhancers at all stages, but with promoters only at epiboly.(D) Pie charts comparing Citrine-only, Cherry-only, and Citrine/Cherry peak number proportions of ATAC-peaks.(E) Genome browser screenshot showing RNA-seq and ATAC-seq profiles in *foxd3* mutant (red) and *foxd3*-control cells (green) within *sox10* locus.(F) Tracks showing normalized ATAC-Rx profiles obtained using reference exogenous *Drosophila* epigenome.(G) Mean density maps of merged profiles and corresponding scatterplots of raw counts for *k*-means clusters featuring elements with differential accessibility and signal levels in *foxd3*-mutant and controls at 5--6ss.(H) Boxplots and heatmap (raw read counts) showing fold change in accessibility and comparing ATAC signal levels between control (C) and mutants (CC) *k*-cluster 3 elements with and without Rx normalization.(I) Bar chart depicting functional annotation of *k*-cluster 3 shows enrichment in zebrafish gene expression ontology terms linked to NC and neural plate development (Bonferroni; ^∗∗^p \< 0.01). For further analysis of *k*-cluster, see [Figure S4](#mmc1){ref-type="supplementary-material"}.(J) Merged profiles for 3,565 elements open at 75% epiboly showed more prominent accessibility defect than at 5--6ss (C ≫ CC, \> 50%), suggesting biological compensation over time.(K and K′) *Cis*-regulatory elements from *k*-cluster 3 show NC-specific reporter activity. (K) Lateral and frontal view of embryos injected with *foxd3*-enh6 and *sox10*-enh2 GFP reporter constructs into the genetic background of *foxd3*-*Cherry* and *sox10*:*BirA-2A-Cherry*, respectively. Scale bars correspond to 100 μm. (K′) Fluorescent and bright-field overlay images of *pax3a* and *ets1* (dorsal view) and foxd3 (lateral view) enhancers. Scale bars correspond to 100 μm.

To investigate whether the accessibility dynamics of distal regulatory elements could account for the drastic depletion of NC specification genes at 5--6ss, we compared the ATAC-seq profiles in *foxd3*-mutant (CC) and *foxd3*-control cells (C) ([Figure 4](#fig4){ref-type="fig"}E). *K-*means clustering identified 8 cohesive groups of elements with 3 general trends: (1) *k*-clusters 1, 4, and 8 contained lower signal elements with prominent accessibility differences between mutant and controls (C ≫ CC), (2) *k*-clusters 5, 6, and 7 comprised elements of equally low comparable accessibility (C ≈ CC), and (3) *k*-cluster 3 contained highly accessible regions with broad ATAC-seq peak distribution that showed intermediate signal decrease in mutants (C \> CC) ([Figure 4](#fig4){ref-type="fig"}G). Functional annotation of *k*-clusters using GREAT Tool ([@bib50]) singled out two clusters reflecting NC regulatory mechanisms---*k*-clusters 3 and 4 showed specific enrichment of zebrafish gene expression ontology terms linked to NC and neural plate development (Bonferroni; ^∗∗^p \< 0.01; [Figures 4](#fig4){ref-type="fig"}I and [S4](#mmc1){ref-type="supplementary-material"}A).

To quantify the observed difference in ATAC-seq signal, we adapted a ChIP-Rx method ([@bib58]) that enables genome-wide quantitative comparative analysis of histone modification ChIP signal (ATAC-Rx). To this end, ATAC was performed on mutant (CC) and control (C) *foxd3*-expressing NC cells at 5--6ss, spiked with *Drosophila melanogaster* S2 cells as a reference exogenous epigenome ([Figure 4](#fig4){ref-type="fig"}F). Quantification after Rx normalization demonstrated a discernible fold-change difference in accessibility between control (C) and mutant (CC) elements ([Figure 4](#fig4){ref-type="fig"}H), thus further confirming the defect in opening of specific distal *cis*-regulatory elements in the *foxd3*-mutant, previously identified by *k*-means clustering.

To investigate dynamics of chromatin opening over developmental time, we performed *k*-means clustering of the 75% epiboly and bud stage ATAC data. We found a subset of *k*-cluster 3 elements was open at 75% epiboly (∼20%; 3,565 el. \[elements\]), with a more prominent change in enhancer accessibility in *foxd3* mutants at this stage (C ≫ CC; \> 50%) as compared to 5--6ss ([Figure 4](#fig4){ref-type="fig"}J), suggesting the defect in foxd3 mutants is compensated over time.

Using an efficient reporter assay in zebrafish, we tested the activity of ∼30 putative regulatory elements from *k*-clusters 3 and 4. *k*-cluster 4 regions were not active at 5--6ss but perhaps are used at later stages, to maintain NC specifiers that remained downregulated in 14--16ss *foxd3* mutants. *k*-cluster 3 elements drove reporter expression at 5--6ss with striking NC-specific activity, recapitulating endogenous expression of their cognate genes ([Figures 4](#fig4){ref-type="fig"}K and 4K′), thus strongly suggesting they act as their *cis*-regulatory elements.

Hotspot Enhancers Associated with Downregulated NC Specification Genes Harbor Specific NC Regulatory Code {#sec2.5}
---------------------------------------------------------------------------------------------------------

*k*-cluster 3 included elements involved in both neural and NC development ([Figure 4](#fig4){ref-type="fig"}I). However, *foxd3*-mutants presented defects only in NC formation, suggesting that neural *cis*-regulatory modules may not require *foxd3* activity for proper function. Further *k*-means clustering of *k*-cluster 3 revealed two pooled subgroups that were generated by assembling subclusters that exhibited similar accessibility characteristics ([Figures 5](#fig5){ref-type="fig"}A--5C): (1) *k*-cluster 3.1 containing *cis*-regulatory elements that displayed lower accessibility in *foxd3* mutants and (2) *k*-cluster 3.2 containing elements with no accessibility change. GREAT analysis further functionally segregated these subclusters: *k*-cluster 3.2 was associated with ontology terms linked only to neural plate and tube development while *k*-cluster 3.1 contained enhancers implicated in NC specification or neuronal differentiation (Bonferroni; ^∗∗^p \< 0.01; [Figures 5](#fig5){ref-type="fig"}D and 5F). From henceforth, we refer to putative elements in *k*-cluster 3.1 as "hotspot enhancers."Figure 5Characterization of Hotspot Enhancers(A) Scatterplot showing subclustering of *k*-cluster 3, one containing elements of lower accessibility in *foxd3* mutants (*k*-cluster 3.1; 12,366 el.; R~Cl3.1~ = 0.77) (B) and the other elements with no change in chromatin accessibility (*k*-cluster 3.2; 4,754 el.; R~Cl3.2~ = 0.97) (C).(B and C) Plots representing genes assigned to *k*-cluster 3.1 (B) and *k*-cluster 3.2 (C) ranked by the number of associated elements. (B′ and C′) Heatmaps showing later expression (14ss) of NC genes depleted in 5--6ss mutant NC. Genes controlled solely by 3.1 elements (in blue) are shown in (B′) and those harboring both 3.1 and 3.2 elements (in red) are depicted in (C′). Genes that remain downregulated at 14ss are labeled in light color print, and those overexpressed are shown in bold.(D and F) Functional annotation by GREAT associates *k*-cluster 3.1 with neural crest specification or neuronal differentiation (D) and *k*-cluster 3.2 with neural plate/tube development (F) (Bonferroni; ^∗∗^p \< 0.01).(E and G) Top transcription factor binding site (TFBS) motifs enriched in 3.1 (E) and 3.2 (G) elements.(H) Venn diagrams showing a number of elements from *k*-clusters 3.1 (in green) and 3.2 (in blue) that are directly bound by foxd3 at premigratory NC (pm-NC) stages (in purple: 75% epiboly, 1--2ss, and 5--6ss ChIP-seq peaks).(I) Comprehensive TF binding motif map representing significantly enriched TFBS for TF expressed at 5--6ss across different *k*-clusters.

To link the putative regulatory elements identified in *foxd3*-mutant (CC) and control (C) NC cells to their transcriptional programs, we first assigned all identified non-promoter ATAC-seq elements to the genes expressed at each corresponding stage ([Figure S4](#mmc1){ref-type="supplementary-material"}C). To connect the transcriptional and regulatory *foxd3* phenotypes at 5--6ss, we assigned hotspot enhancers (*k*-cluster 3.1) and elements from *k*-cluster 3.2 to the corresponding genes expressed at this stage and ranked those genes by the number of elements associated ([Figures 5](#fig5){ref-type="fig"}B and 5C). Hotspot enhancers correlated to the ensemble of NC specification genes downregulated at 5--6ss with high statistical significance (^∗∗∗∗^p = 1.12E−60). Moreover, no other *k*-cluster, including 3.2, showed significant association to genes either up- or downregulated in the *foxd3*-mutant at 5--6ss.

A number of NC specifiers that were downregulated in *foxd3*-mutants at 5--6ss recovered their expression by 14ss. We inquired whether *k*-cluster 3.2 regulatory elements (unaffected by loss of foxd3) could act instead of hotspot *k*-cluster 3.1 enhancers to rescue cognate gene expression. However, the genes controlled by both hotspot enhancers and *k*-cluster 3.2 elements ([Figure 5](#fig5){ref-type="fig"}C′) compared to those controlled solely by hotspot elements ([Figure 5](#fig5){ref-type="fig"}B′) did not recover more efficiently (50% versus 40% of genes, respectively, were still depleted in *foxd3*-mutants at 14ss). Instead, an important fraction (∼25%) of downregulated NC specifiers harboring 3.2 elements, were, in fact, upregulated in 14ss *foxd3*-mutant NC, and such upregulation was not observed for genes solely controlled by hotspot activating enhancers. Moreover, genes differentially upregulated at 14ss associated to *k*-cluster 3.2 with high statistical significance (p = 4.73E−74), suggesting that *k*-cluster 3.2 elements, were in fact linked to foxd3-mediated repression.

In line with their predicted assigned functions, transcription factor binding site (TFBS) analysis using Homer suite ([@bib24]) revealed that *k*-cluster 3.1 (hotspot enhancers) and *k*-cluster 3.2 elements harbored distinct regulatory codes. Hotspot enhancers presented a canonical neural crest signature featuring *bona fide* NC master regulators Sox10 ([@bib67]), TFAP2a, and nuclear receptor NR2 ([@bib63]) as top enriched binding motifs ([Figure 5](#fig5){ref-type="fig"}E), while *k*-cluster 3.2 top enriched motifs were Lhx2/3, a transcription factor involved in neural development and cortical neurogenesis ([@bib7]), Oct4-Sox2, and multiple FoxA motifs ([Figure 5](#fig5){ref-type="fig"}G). Interestingly, the only other *k*-clusters that were enriched in NC motifs (TFAP2a and Ets1, but not Sox10) were *k*-clusters 1, 4, and 8 ([Figure S4](#mmc1){ref-type="supplementary-material"}B), suggesting that regulatory elements whose opening is dependent on foxd3 display unifying features of an NC enhancer. Furthermore, we also found a number (∼10%) of hotspot and *k*-cluster 3.2 elements were directly bound by foxd3 at premigratory stages ([Figure 5](#fig5){ref-type="fig"}H). Given the paucity of available zebrafish TFBSs, we also formulated a new approach to build comprehensive TF binding motif maps for each enhancer *k*-cluster to be used in statistical enrichment analyses. Similarly, the majority of NC TF motifs were present in the hotspot *k*-cluster 3.1 neural crest enhancers ([Figure 5](#fig5){ref-type="fig"}I), while *k*-cluster 3.2 elements clearly lacked sox10, nr2f, and most pax motifs, except for a single pax cluster, comprising human TF binding motifs for Pax3 and Pax7, previously shown to control both NC, neuronal and mesenchymal derivatives ([@bib48], [@bib53]). Moreover, *k*-cluster 3.2 enhancers harbored the majority of hnf, tcf, klf, zic, and pou motifs, suggesting these elements could both drive NC derivative as well as stem cell maintenance programs at later stages of NC development and mediate repressive activity.

This analysis singled out *k*-cluster 3.1 as the *bona fide* NC enhancer cluster that contained hotspot *cis*-regulatory modules driving NC specification genes at premigratory stages. Defects in the chromatin accessibility of these hotspot enhancers resulted in the decrease of NC specifiers' expression in *foxd3* mutants.

foxd3 Primes Late Regulatory Elements Used in Migratory NC {#sec2.6}
----------------------------------------------------------

To quantitatively evaluate events of chromatin opening at 5--6ss, we performed differential accessibility analysis using the DiffBind package ([@bib73]). We identified 900 peaks that were differentially accessible in *foxd3*-control (C) versus *foxd3*-mutant (CC) neural crest ([Figures 6](#fig6){ref-type="fig"}A--6C); these elements exhibited low signal at 75% epiboly, only starting to open at 5--6ss, but were clearly accessible in the NC at 16ss ([Figure 6](#fig6){ref-type="fig"}D). Functional annotation of identified elements revealed significant enrichment of GO terms for stem cell development and differentiation, neural crest differentiation and migration, and mesenchymal cell differentiation (^∗∗^p \< 0.01), as well as gliogenesis (^∗^p \< 0.05), further suggesting these regions may act as *cis*-regulatory elements at later stages of NC ontogeny ([Figure 6](#fig6){ref-type="fig"}E). Interestingly, assigned genes included cell adhesion and migration factors that were de-repressed in *foxd3* mutant NC at later stages. Conversely, other associated NC regulatory factors that drive specific NC lineages and are normally highly expressed at later stages were depleted in the *foxd3* mutant at 14ss ([Figure 6](#fig6){ref-type="fig"}A). These results clearly suggest that, in addition to the NC specification program at premigratory NC stages, foxd3 continues to aid the opening of the *cis*-regulatory elements associated with NC differentiation, while, at the same time, negatively controlling gene expression of cell surface and migration machinery that ultimately has to be deactivated in order for cells to settle and differentiate. Importantly, association of stem cell development/differentiation genes to late NC enhancers further supports a role for foxd3 in controlling stem cell identity in the migrating and differentiating NC.Figure 6Differential ATAC-Seq Analysis and Clustering of Enhancers Based on H3K27Ac Profiles(A) Annotated MA plot depicting late opening enhancers significant by DiffBind analysis (p \< 0.05, FDR\<0.1) of the ATAC-seq signal at 5--6ss with annotated associated genes (stem cell genes, blue; cell adhesion/migration cues, green; NC specification and differentiation, red).(B) Genome browser screenshot exemplifying the type of element isolated by DiffBind (boxed).(C and D) (C) Heatmap (raw read counts) of all elements and (D) collapsed merged profiles indicating that identified elements are closed at epiboly and only start to open at 5--6ss.(E) Functional annotation of DiffBind-identified enhancers shows association with later roles in NC (^∗∗^p \< 0.01).(F--H) (F) Heatmap depicting *k*-means linear enrichment clustering of H3K27Ac signal across non-promoter ATAC-seq peaks in *foxd3*-mutant (CC, Citrine/Cherry) and control (C, Citrine) at 5--6ss, (G) associated mean merged profiles for selected clusters, and (H) corresponding ontology enrichment bar plots indicating functional role of selected clusters.(I) Heatmaps showing expression of NC specification genes (log FPKM) associated with K27Ac_Cl5 at 5--6ss and NC migration/differentiation genes associated with K27Ac_Cl9 at 14ss in *foxd3*-mutant (CC) and control cells (C).(J) Heatmap depicting expression at 14ss of canonical and non-canonical Wnt pathway molecules (in log FPKM) associated with K27Ac_Cl8 that displays an increase in enhancer K27 acetylation in mutants.(K) TF binding motif map representing significantly enriched TFBS for TF expressed at 5--6ss across different K27Ac-clusters. See [Figure S5](#mmc1){ref-type="supplementary-material"} for other K27Ac clusters and corresponding ontology enrichment bar plots.

Taken together, our findings demonstrate that foxd3 controls NC gene activation by acting at a *cis*-regulatory level both during early NC specification and at later migratory NC stages. This realization contributes to converging evidence that foxd3 plays multiple, sometimes opposing, roles, particularly during the transition from NC specification to migration/differentiation stages.

H3K27Ac on NC Enhancers Is Altered in foxd3 Mutants {#sec2.7}
---------------------------------------------------

To examine whether H3K27 acetylation, a hallmark of active enhancers, was affected in *foxd3*-mutant NC at 5--6ss, we carried out H3K27Ac ChIP using FAC-sorted *foxd3*-mutant (CC) and control *foxd3*-expressing NC cells (C). *k*-means clustering of H3K27Ac signal identified 10 clusters with differential patterns of H3K27 acetylation on putative *cis*-regulatory elements ([Figures 6](#fig6){ref-type="fig"}F, 6G, and [S5](#mmc1){ref-type="supplementary-material"}). Four clusters (K27Ac_clusters 1, 2, 3, and 6) contained elements with no change in H3K27 acetylation, whereas four clusters showed a decrease (K27Ac_Cl5, 7, 9, and 10) and two an increase (K27Ac_Cl4 and Cl8) in H3K27Ac signal in *foxd3* mutant NC. In K27Ac_Cl5, acetylation in *foxd3*-mutants was abrogated below background levels, possibly indicating active removal of the H3K27Ac mark from the enhancers when they were not primed or bound by NC-specific TFs. Functional annotation of this cluster yielded specific enrichment of zebrafish GO terms linked to early (premigratory) NC, as well as nervous system development (Bonferroni; ^∗∗^p \< 0.01; [Figure 6](#fig6){ref-type="fig"}H). The majority of NC genes downregulated in *foxd3* mutants at 5--6ss were associated with one or more K27AC_Cl5 elements (p = 1.59E−05; [Figure 6](#fig6){ref-type="fig"}I), suggesting that some of the enhancers initially opened by foxd3 and used during early NC specification also depended on this factor for appropriate acetylation. Similarly, H3K27Ac_Cl9 elements, characterized by strong K27Ac signal in controls and defect in *foxd3*-mutant cells ([Figure 6](#fig6){ref-type="fig"}G), were mainly associated with factors regulating late NC events such as migration and differentiation into derivatives such as cranial skeletal elements ([Figure 6](#fig6){ref-type="fig"}H). Interestingly, a number of these genes were upregulated in *foxd3*-mutants by 14ss, indicating a supplementary *foxd3*-linked gene and enhancer regulatory mechanism ([Figure 6](#fig6){ref-type="fig"}I). The putative role of foxd3 in repression of these NC genes until post-migratory stages is reminiscent of the observations made in studies of Foxd3 function in germ and pluripotent stem cells ([@bib37], [@bib64]).

In contrast, the increased H3K27 acetylation in *foxd3*-mutants suggests foxd3 involvement in active removal of this histone modification from cluster K27Ac_Cl8 enhancers that control of Wnt signaling pathway components ([Figures 6](#fig6){ref-type="fig"}G and 6H). Correspondingly, both canonical Wnt signaling ligands (*Wnt1*,*3*,*3a*,*8a/b*, *10a/b*), receptors (*fzd3*,*8b*,*10*, *fzdb*, *sfrp1a*), signal transduction effectors (*apc*, *axin2*, *wntless*, *tcf3a/b*, *tcf15*), as well as non-canonical Wnt signaling ligands (*wnt4a*,*5b*, *7b*,*11*,*11r*,*16*) and signal transduction effectors (*daam1a/b*, rho, *plc*, *nfat3b*), were differentially upregulated in *foxd3*-mutants at 14ss ([Figure 6](#fig6){ref-type="fig"}J).

Interestingly, DNA motif enrichment patterns identified in individual K27Ac clusters differed from binding maps of hotspot *k*-cluster 3.1 enhancers. For instance, elements from K27Ac_Cl5 cluster, featuring complete repression in H3K27Ac signal in *foxd3*-mutants, lacked enrichment in sox, prdm, or pax3/7 motifs but harbored motifs for other pax TFs (pax1/9, pax2/5/8, pax6) and ets (erythroblast transformation specific). In general, K27Ac clusters containing elements acetylated in a *foxd3*-dependent manner (K27Ac_Cl5, 7, 9, and 10; [Figures 6](#fig6){ref-type="fig"}F and 6G) showed enrichment in tfap2, nr2f, and zic motifs, while elements from clusters K27Ac_Cl4 and 8, which may normally require foxd3 binding for maintenance of repressive state ([Figures 6](#fig6){ref-type="fig"}F and 6G), are enriched in binding motifs for neural and stem cell TF sox2. Regions of low acetylation across ATAC peaks in K27Ac_Cl3_6 are enriched in CTCF binding motifs ([Figure 6](#fig6){ref-type="fig"}K).

These results show that foxd3's effects on H3K27 acetylation of enhancers are context dependent. While correlating positively with H3K27ac deposition on enhancers of early specification and late fate commitment genes, foxd3-dependent H3K27Ac is negatively associated with expression of Wnt signaling genes.

Ectopic Expression of foxd3 Modifies the Chromatin Landscape in Early Embryos {#sec2.8}
-----------------------------------------------------------------------------

Under some conditions, FoxD3 has been shown to auto-regulate itself ([@bib26], [@bib46], [@bib61]). Indeed, here we reveal that in *foxd3*-mutants, the transcription of truncated *foxd3* form was increased at 75% epiboly, depleted at 5--6ss and again upregulated at 14--16ss, indicating different feedback loops controlling *foxd3* expression at different stages of development. To investigate the direct action of foxd3-mediated chromatin priming and subsequent gene activation, we performed *foxd3* overexpression experiments by injecting *foxd3* mRNA into heterozygous *Gt(foxd3-mCherry)*^*ct110*^ embryos ([Figure 7](#fig7){ref-type="fig"}A). To assess the degree of auto-regulation upon ectopic *foxd3* expression versus control, we first quantified fluorescence intensity and the number of endogenous foxd3-mCherry cells at 50% epiboly by FACS ([Figures 7](#fig7){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}A). While we did not observe an increase in fluorescent cell number, we noticed an overall increase in the fluorescence intensity when compared to control non-injected embryos, consistent with supplemental gene activation at the *foxd3*-*mCherry* locus. Remarkably, cells from *foxd3* mRNA-injected embryos failed to exhibit the highest mCherry fluorescence found in the control cells ([Figure 7](#fig7){ref-type="fig"}B; P5 compartment -- black arrow), suggesting also a potential repression at the *foxd3*-*mCherry* locus. Our findings suggest that foxd3 both activates and represses itself and that its activity may be dependent on the concentration and spatial position of the cells within an embryo. Thus, under overexpression conditions, the bimodal action of foxd3 may occur at an even earlier stage than normal.Figure 7Putative Mechanisms of the Bimodal foxd3-Mediated NC Gene Regulation(A) Experimental strategy for *foxd3* overexpression *in vivo*. *Gt(foxd3-mCherry)*^*ct110*^ heterozygous embryos were used for FACS and wild-type embryos for ATAC-seq experiments at 50% epiboly stages. For ATAC-seq, embryos were dissected (dashed lines) to only collect "foxd3-naive" cells that do not normally express foxd3. Native and ectopic foxd3 expression is illustrated in dark pink and lighter pink, respectively.(B) FACS graph portraying a number of *foxd3-mCherry* expressing cells and underlying fluorescence intensities from control (green) and *foxd3* mRNA injected (pink) embryos. P1--P5 -- compartments of different fluorescence levels from the lowest to the highest. Black arrow indicates a loss of highest intensity fluorescence in *foxd3* mRNA injected embryos versus control. (B′) Genome browser screenshot depicting region ∼60 kb upstream from the *foxd3* transcription start site (TSS). Green and pink ATAC-seq tracks represent genome accessibility from control and *foxd3* overexpressing embryonic cells. Purple arrows indicate either relative loss or acquisition of chromatin accessibility upon *foxd3* overexpression.(C) Mean density maps of merged profiles for *k*-means clusters featuring elements with differential accessibility between the *foxd3* mRNA injected (in pink) and control (in green) 50% epiboly-staged embryos using either foxd3 binding maps or *k*-cluster 3.1 elements as a reference.(D) Circle plot showing statistically significant TF motif co-occurrences on the "early NC" foxd3-bound activating elements.(E) Circle plot showing different statistically significant TF motif co-occurrences on the "late NC" foxd3-bound elements, underlying repressive activity.(F) *De novo* TF binding motifs enriched within foxd3-bound elements associated with NC genes negatively regulated by foxd3 at 14ss.(G) Nucleosomal occupancy profiles expressed as relative NucleoATAC normalized cross-correlation signals. Profiles show changes in nucleosome positioning within the regulatory elements in control (C; green) and *foxd3*-mutant (CC; red) cells. Direct foxd3 binding at either early (epiboly, 1--2ss in magenta) or late stage (5--6ss, 14ss in green) results in either nucleosome clearing (G′; permissive role) or nucleosome compaction (G″; repressive role). Both processes are altered and nucleosomal patterns inverted in *foxd3*-mutant NC (G′ and G″).(H) Mean density maps of merged profiles of nucleosomal clusters obtained by *k*-means analysis showing differential nucleosomal patterns between *foxd3*-mutants (CC; red) and controls (C; green). Both nucleosome-loose clusters of elements with activating patterns (epi-activate and 5--6ss-activate) and nucleosome-compact clusters with repressive patterns (epi-repress and 5--6ss-repress) are identified. (H′) Bubble chart depicting functional annotation of different nucleosomal clusters by GREAT (Bonferroni; p \< 0.01). Only elements directly bound by foxd3 are analyzed.

To probe foxd3's capability to prematurely prime *cis*-regulatory elements, we again overexpressed it but, this time, dissected the embryos to analyze chromatin accessibility (ATAC-seq) in cells that do not normally express foxd3 endogenously at this stage ("foxd3-naive" cells) ([Figure 7](#fig7){ref-type="fig"}A). When comparing datasets from *foxd3*-injected embryos versus controls, we failed to detect the opening of *de novo* genomic regions that were not normally accessible in the *foxd3*-expressing cells. This suggests that foxd3 activity remains specific to a defined set of putative downstream targets. Interestingly, we observed that ectopic foxd3 activity increased accessibility of a large number of putative elements directly bound by foxd3 (as uncovered in our ChIP experiments), including a number of hotspot enhancer elements ([Figure 7](#fig7){ref-type="fig"}C). Elements that showed enhanced accessibility upon ectopic *foxd3* expression associated with genes involved in early neural plate and neural crest development and in particular with those controlling Wnt and BMP signaling ([Figures S6](#mmc1){ref-type="supplementary-material"}B and S6B′). Furthermore, within the *foxd3* genomic locus itself, we identified *cis*-regulatory elements showing changes in accessibility in both directions upon *foxd3* expression ([Figure 7](#fig7){ref-type="fig"}B′, purple arrows). Bimodal auto-regulation of *foxd3* ([Figures 7](#fig7){ref-type="fig"}B and 7B′) offers an excellent example of foxd3's capacity to both activate and repress a gene by priming or decommissioning different *cis*-regulatory elements.

*In silico* Combinatorial Transcription Factor Analysis Suggests Distinct Gene Regulatory Mechanisms Underlie the Bimodal Action of foxd3 {#sec2.9}
-----------------------------------------------------------------------------------------------------------------------------------------

Because late *cis*-regulatory regions were not fully opened by ectopic *foxd3* expression, we speculated that foxd3 likely requires *in vivo* interacting partners to exert its bimodal activity. To identify putative foxd3 partners, we analyzed the underlying foxd3 biotin ChIP sequences during either gene activation or gene repression. The classification of foxd3-bound regulatory elements solely using one of the bimodal actions was based on the assumption that these roles are temporally distinct, with foxd3 mainly acting as activator during early stages (75% epiboly; 1--2ss; "early" peaks), and as a repressor at later stages of NC ontogeny (5--6ss; 14ss). Given that at the 5--6ss foxd3 may mediate both activities, the set of "late" peaks was obtained by removing peaks already bound at earlier stages, thus focusing primarily on the foxd3-repressed genomic loci. After *de novo* TF binding motif enrichment analysis on early and late foxd3-bound NC genomic regions, we selected 20 out of 20 identified (early) and 27 out of 32 identified (late) significantly enriched sequence motifs to be used for *in silico* 2-way TF combinatorial analysis. For visualization purposes, different motifs annotated to the same TF were pooled ([Figures 7](#fig7){ref-type="fig"}D, 7E, [S6](#mmc1){ref-type="supplementary-material"}C, and S6D). Combinatorial analysis yielded a signature of putative foxd3 co-activators at early stages (Sox3, SP1, Zic, Hnf1ba, Pou6f1, zinc-finger protein (ZFP), Zbtb3, and Smad4) ([Figure 7](#fig7){ref-type="fig"}D). Conversely, late stage peaks were enriched for NFY, SP1, Otx2, Sox10, E2F6, Rxr, bZIP, Nr2c2ap, Foxd3, and other Fox-like TF motif complexes ([Figure 7](#fig7){ref-type="fig"}E). Given that some of the lineage specification factors enriched at later stages overlap foxd3 binding genomic coordinates, we cannot unequivocally discriminate whether these factors co-operate or compete with foxd3. Surprisingly, we did not observe an extensive enrichment of fox/foxd3 motifs from our foxd3 biotin ChIP-seq sets at early NC stages (when foxd3 is mostly playing a priming role), while fox/foxd3 were the most highly enriched out of all motifs at foxd3-bound DNA sequences at later NC stages (when foxd3 primarily acts as a repressor) ([Figures 7](#fig7){ref-type="fig"}D, 7E, [S6](#mmc1){ref-type="supplementary-material"}C, and S6D). This is suggestive of differences between foxd3 binding affinities during its priming versus repressive modes and is consistent with previous studies showing that some co-binding pioneer transcription factors exhibit only a partial DNA sequence motif recognition when binding to the nucleosome, but recognize canonical motifs when binding "naked" DNA ([@bib71]). Thus, our findings support the hypothesis that foxd3 is a bimodal NC regulator, which progressively changes from a co-pioneering factor toward a repressor during NC ontogeny.

Foxd3 Mediates Gene Repression via Chromatin Modulation together with Other Factors {#sec2.10}
-----------------------------------------------------------------------------------

To focus on potential factors that may directly co-repress NC genes at later stages, we scanned foxd3-occupied genomic loci associated with genes significantly upregulated in the 14ss *foxd3*-mutant NC for *de novo* TF binding motifs. Interestingly, only three significantly enriched motifs were identified: foxd3 (MF0005.1_Forkhead_class/Jaspar(0.813); p = 1E−15), e2f6 (MA0471.1_E2F6/Jaspar(0.722), p = 1E−14), and Esrra (MA0592.1_ESRRA/Jaspar(0.800), p = 1E−12) ([Figure 7](#fig7){ref-type="fig"}F). E2F6 was found to co-occupy the highest proportion of foxd3-bound repressive peaks (16.55%) ([Figure 7](#fig7){ref-type="fig"}F).

Next, we identified a set of genomic regions accessible early (75% epiboly; 1--2ss), then bound by foxd3 from 5--6ss and ultimately closed by 14--16ss, suggesting foxd3-facilitated compaction. Such regulatory elements (314) were associated to 293 gene loci, 44% of which were upregulated in *foxd3*-mutants at 14ss, indicating these were directly regulated by foxd3 via modulation of chromatin accessibility at enhancers. Moreover, GREAT analysis revealed a significant enrichment for neuronal fate specification terms ([Figure S6](#mmc1){ref-type="supplementary-material"}E′; ^∗∗^p \< 0.01), including genes such as *olig2/4*, *mnx1*, *fgf8a*, *gli1*, *neurog1*, and *robo1*, confirming our previous observations that foxd3 prevents premature activation of neuronal pathways ([Figure 2](#fig2){ref-type="fig"}H). TF motif enrichment analysis of these 314 elements using the same initial set of 32 motifs ([Figure 7](#fig7){ref-type="fig"}E) yielded 19 significant co-occurring motifs (12 different TFs) ([Figure S6](#mmc1){ref-type="supplementary-material"}E). We again noted promiscuous foxd3 binding, as the top five different fox/foxd3 motifs were enriched on 85% of repressed loci. Interestingly, 98.1% of all repressed loci exhibited the Hnf1b a/b motif sequence, while other predominantly enriched motifs underlying foxd3-mediated co-repression were otx2 (92.7%), sox10 (79.9%), two NFY motifs (78.7% and 79.9%), and e2f6 (70.7%). Combinatorial TF analysis showed that fox motif factors had the highest number of statistically significant co-occurrences, followed by foxd3 co-occupation with sp1, zfp-like, e2f6, otx2, sox3, NFY, znf-irf1, hnf1b a/b, and sox10 motifs ([Figure S6](#mmc1){ref-type="supplementary-material"}E). Otx2, sox3, and sox10 factors, involved in NC differentiation and neural development, may not co-operate with foxd3 to mediate repression but rather compete for underlying binding sequences to promote multipotent NC cell differentiation ([@bib6], [@bib13], [@bib17]). Conversely, e2f6 factor is known to function as a transcriptional repressor that associates with Polycomb repressive complexes (PRC1 and PRC2) ([@bib21], [@bib42], [@bib77]). We explored e2f6/foxd3 co-operation in transcriptional repression by scanning four different e2f6 motifs across all foxd3-bound regions associated with the genes upregulated in 14ss *foxd3*-mutant embryos ([Figure 3](#fig3){ref-type="fig"}E) and found that 82.3% of them were significantly enriched for e2f6 binding (chi-square test; ^∗∗∗^p \< 0.0004). This indicates that e2f6 likely plays an important role in NC development by co-operating with foxd3 to repress target genes in order to maintain NC multipotency.

Foxd3 Affects Nucleosomal Positioning on NC Enhancers {#sec2.11}
-----------------------------------------------------

Our analysis suggests that foxd3-mediated chromatin compaction at regulatory elements is one mechanism employed for specific gene repression. However, the role of foxd3 in gene activation and maintenance may involve other mechanisms including nucleosomal rearrangements at NC enhancers. FoxD3 forkhead DNA binding domain, like that of FoxA proteins, is composed of three helices and two large loops ("wings"), remarkably similar to the winged-helix structures of linker histone H1 that avidly binds nucleosomes ([@bib16]). Such pioneer factors have been suggested to induce nucleosome repositioning, possibly by recruiting hyperdynamic histone variants, such as H2A.Z and H3.3 and other chromatin and DNA modifying proteins, to allow binding of *cis*-regulatory elements by transcriptional complexes ([@bib14], [@bib72], [@bib91]). To assess whether foxd3 affects nucleosomal positioning on NC enhancers, we analyzed nucleosome profiles in *foxd3*-mutant and control neural crest cells. To this end, we generated nucleosomal occupancy tracks using the NucleoATAC algorithm that enables calling nucleosome positions using Tn5 footprints embedded in ATAC-Seq data ([@bib68]). *k*-means clustering identified cohesive groups of elements that presented significant differences in nucleosomal patterns between *foxd3*-mutant (CC) and control (C) NC. Interestingly, while no changes in chromatin architecture at promoters were observed, nucleosomal clustering at 5--6ss singled out groups with differential nucleosomal density in *foxd3*-mutants ([Figure S6](#mmc1){ref-type="supplementary-material"}F). Overall, we found that foxd3 influences the nucleosome positioning at NC regulatory elements in a context-dependent manner, resulting in both "permissive" and "repressive" chromatin organizations ([Figure 7](#fig7){ref-type="fig"}G). We find clear evidence of permissive foxd3 occupancy resulting either in the removal of the nucleosomes from the core enhancer region (early foxd3 binding; 75% epiboly to 1--2ss) or maintenance of nucleosome-free conformation (later foxd3 binding, from 5--6ss). Both processes were altered in *foxd3*-mutants, resulting in compaction of enhancer cores that are habitually nucleosome-free ([Figure 7](#fig7){ref-type="fig"}G′). Conversely, at other elements, repressive foxd3 binding was associated with the nucleosomal maintenance and compaction, as absence of functional foxd3 protein in mutant NC resulted in clearing of nucleosomes from enhancer cores ([Figure 7](#fig7){ref-type="fig"}G″).

To analyze genome-wide changes in nucleosomal positioning at gene regulatory regions upon *foxd3* gene perturbation, we performed *k*-means clustering and identified cohesive groups of elements showing differential nucleosomal patterns between *foxd3*-mutants and controls. At both stages of development analyzed (75% epiboly and 5--6ss), we identified clusters of nucleosome-loose elements with activating patterns and nucleosome-compact clusters with repressive patterns but displaying opposite nucleosomal positioning in *foxd3*-mutants ([Figure 7](#fig7){ref-type="fig"}H). Functional annotation of foxd3-bound regulatory elements belonging to the identified nucleosomal clusters at early stage suggests foxd3-directed activation of NC and stem cell development programs, as well as preparation for neural crest migration ([Figure 7](#fig7){ref-type="fig"}H′; epi-activate). Concurrently foxd3 appears to directly negatively control premature NC and stem cell differentiation, and formation of derivatives (peripheral nervous system, melanocytes) ([Figure 7](#fig7){ref-type="fig"}H′; epi-repress). Similarly, in the *bona fide* premigratory NC cells at 5--6ss, foxd3-mediated rearrangements of nucleosomes directly control activation of relevant signaling pathways (FGF, ERK1-ERK2 MAPK, as well as non-canonical Wnt signaling), as well as the onset of gliogenesis ([Figure 7](#fig7){ref-type="fig"}H′; 5--6ss-activate), while, at the same time, directly repressing late differentiation events (pigment cells, axonogenesis) and components of signaling pathways no longer active in migrating crest (Id, Notch/Delta) ([Figure 7](#fig7){ref-type="fig"}H′; 5--6ss-repress).

Discussion {#sec3}
==========

Gene expression is the product of interplay between proximal and distal *cis*-regulatory elements, controlling competence at the chromatin level ([@bib57], [@bib80]). Moreover, broad epigenetic changes to the *cis*-regulatory landscape, including histone and DNA demethylation, histone acetylation, and loss of heterochromatin characterize different stages of transition from naive to primed pluripotency ([@bib36]). Several mechanisms explaining how Foxd3 promotes pluripotency *in vitro* have been proposed. FoxD3 can recruit Tle4 to repress differentiation-associated genes induced by NFAT signaling through regulation of histone de-acetylation ([@bib93]). In two recent studies investigating the transition from ESCs to EpiCs, EpiLCs, and PGCKs, mouse FoxD3 was implicated in the regulation of stem cell pluripotency by associating to different enhancer marks and subsequently manipulating transcriptional competency of downstream genes ([@bib45]). The first report showed that FoxD3-bound enhancers associated with genes primed for expression upon exit from naive pluripotency, with FoD3 promoting nucleosome depletion by recruiting SWI/SNF complex chromatin remodeler Brg1, while simultaneously acting as a repressor and preventing enhancer acetylation by recruiting HDACs ([@bib37]). The other study showed that FoxD3-bound active enhancers associated with highly expressed genes that become silenced upon exit from naive pluripotency, where corresponding enhancers were decommissioned through recruitment of Lsd1, and a reduction in p300 activity ([@bib64]). Surprisingly, the two studies found a minimal overlap (only ∼12%) in FoxD3 bound peaks ([@bib60], [@bib75], [@bib90]). The discrepancies between the different putative mechanisms of FoxD3 re-enforced the need for *in vivo* studies that would characterize the regulatory context within which FoxD3 mediates different activator and repressor roles across developmental time.

Foxd3 Is a Pioneering Factor for NC Specification {#sec3.1}
-------------------------------------------------

The studies described above suggest FoxD3 plays an array of complex independent roles during NC ontogeny, but its role during NC specification has remained elusive. Although Foxd3 was thought to act mostly as a transcriptional repressor, previous reports failed to recover more differentially upregulated versus downregulated genes in *foxd3* mutant cells ([@bib64], [@bib87]). Strikingly, our analysis showed that foxd3 plays a central activating role in NC specification, both directly and indirectly controlling the expression of an entire NC specification module. We present evidence that foxd3 acts at a global level to prime NC factors by modulating the accessibility of their *cis*-regulatory elements. Thus, much like its relatives, FoxA1 and FoxA2, shown to regulate enhancer dynamics for specific gene expression controlling pluripotent stem cell potential, cell fate transitions, lineage choice, and differentiation ([@bib1], [@bib69], [@bib91]), foxd3 acts as a pioneer factor in the NC. By studying dynamics of chromatin opening across several stages, we identified a set of hotspot enhancers, a substantial portion of whose accessibility was dependent on a direct foxd3 binding. Quantification of accessibility levels using normalized ATAC assay and statistical differential binding analysis indicated that defects in *foxd3*-mutant cells are most striking at the onset of enhancer opening and affect early genes at the onset of NC specification, late genes at the onset of migration and genes involved in the multipotent progenitor potential maintenance.

Foxd3 Affects H3K27 Acetylation on NC Enhancers {#sec3.2}
-----------------------------------------------

Previous studies suggested that one of the *modi operandi* of pioneer factors was the recruitment of H3K27 acetyltransferase activity, a hallmark histone modification of active enhancers ([@bib15], [@bib32]). In contrast, a recent report found that, following FoxA1/A2 activity, accessible nucleosomes in liver-specific enhancers had reduced H3K27Ac, suggesting that the initial role of pioneer factors in opening and controlling nucleosome occupancy at enhancers was temporally uncoupled from the acetylation role ([@bib27]). We found that lack of foxd3 during NC specification resulted in differential K27 acetylation, with some NC regulatory elements showing depletion and others an increase in H3K27Ac mark in mutant embryos. We show that early NC specifiers, downregulated in *foxd3*-mutants, are controlled positively via this mechanism, as they associated to the K27Ac-depleted elements with a high statistical significance. At the same time, we demonstrate that those *cis*-regulatory elements, which show significant areas of hyperacetylation in mutants, negatively control essential components of Wnt signaling pathway. Therefore, in NC cells foxd3 activity both enables and inhibits H3K27 Acetylation of NC regulatory elements, thus promoting both the activation of NC specification genes and the repression of factors that need to be downregulated for the NC migration/differentiation to proceed.

Bimodal Action of foxd3 {#sec3.3}
-----------------------

Here, we present strong evidence that during NC formation *in vivo*, in addition to its conventional role as a repressor ([@bib87]), foxd3 acts as a pioneer factor to prime NC gene expression. In line with recent *in vitro* studies ([@bib37], [@bib64]), we demonstrate that foxd3 functions primarily by changing the chromatin landscape of *cis*-regulatory elements and sets up a number of hotspot NC gene enhancers (*k*-cluster 3.1), as well as later migratory NC regulatory elements required for the specification of distinct NC lineages. The foxd3 binding to the NC enhancers that were associated with the downregulated genes in the absence of foxd3 is strongly indicative of its direct central role in NC gene activation via enhancer priming during early steps of NC ontogeny. On the other hand, later in NC development, foxd3 represses or decommissions a considerable number of active enhancers associated with mesenchymal or neuronal genes found upregulated in *foxd3*-mutants. This indicates that, in the developing embryos, foxd3 is capable of modulating the NC chromatin regulatory landscape in a bimodal fashion, facilitating both permissive and repressive states. These mechanisms do not exhibit sharp temporal boundaries but instead occur concomitantly, with a gradual shift toward the repressive activity after NC specification. Whether such bimodal activity of foxd3 could enable early NC fate transitions and maintenance of multipotency remains to be investigated in future.

Distinct Regulatory Co-factors Likely Underpin foxd3's Dual Mechanisms of Action {#sec3.4}
--------------------------------------------------------------------------------

Regulation of gene expression is largely determined by co-operative interactions between different transcription factors that are dependent on underlying DNA binding motifs ([@bib30]). For instance, another Fox pioneering factor, FoxA, was shown to both promote gene expression but also to co-occupy the enhancers of silenced genes such as *cdx2* together with transcriptional repressors such as Rfx and type II nuclear hormone receptor ([@bib82]). Our combinatorial TF analyses uncovered a number of novel foxd3 co-factors required for either gene priming or repression that together control NC induction and maintain NC multipotency. One of the identified putative foxd3 co-binding partners required for the pioneering activity, zbtb3, was previously shown to be critical in the early embryonic development and stem cell self-renewal by promoting Nanog expression in mice ([@bib88]). Interestingly, its fly homolog GAF was shown to influence chromatin organization, including promoting nucleosome removal by associating with chromatin remodeling complexes, such as nucleosome remodeling factor or facilitates chromatin transcription (FACT) ([@bib2]). Furthermore, ZFPs were revealed as most likely foxd3 partners during early NC development. Intriguingly, BRG1, a catalytic subunit of chromatin remodeling SWI/SNF complex previously shown to interact with foxd3 ([@bib37]), is known to be attracted to targeted chromatin regions via its N-terminal ZFP-interaction domain ([@bib29]). Thus, our results suggest foxd3/ZFP-dependent recruitment of Brg1 to the associated enhancers that subsequently leads to nucleosome depletion and enhancer activation. Other known NC factors, such as zic and tfap2, also seem to be playing a co-pioneering role together with foxd3 in early NC development as previously shown using foxd3/tfap2 double mutant analyses ([@bib81]).

In search of co-repressing partners of foxd3, we identified a putative novel NC regulator, e2f6, that potentially co-represses NC differentiation genes together with foxd3. E2F6 exerts its repressive functionality through recruitment of PRC complexes in a DNA sequence-targeted fashion ([@bib4], [@bib56], [@bib77]). Notably, a previous study exploiting a similar strategy to ours to uncover TF motif co-occurrences on FoxA2 binding sites, which were associated with upregulated genes in FoxA1/2 mutants, also identified E2F6 as a potential co-repressor in mouse liver cells ([@bib27]).

Here, we present striking evidence that, during NC ontogeny, foxd3 may switch from permissive to repressive nucleosome/chromatin organization of NC *cis*-regulatory elements to independently control NC specification and NC differentiation events. Furthermore, we identified potential distinctive transcription co-factors at different stages of NC ontogeny, indicating possible mechanisms underlying foxd3 bimodality. Thus, our current data provide a platform for future hypothesis-driven experiments that will be crucial for deciphering the exact mechanism of foxd3 bimodality underlying NC gene regulation *in vivo*.

The beta version of the interactive ShinyApp associated with the data produced in this study and Pagoda App ([@bib20]) presenting single-cell catalogs can be downloaded from <https://github.com/tsslab/foxd3>. The live app can also be accessed here: <https://livedataoxford.shinyapps.io/FoxD3-project-TSS-Lab/>.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**H3K27ac antibodyAbcamCat\#Ab4729; RRID: [AB_2118291](nif-antibody:AB_2118291){#interref0015}IgG antibodyMilliporeCat\#12-370; RRID: [AB_145841](nif-antibody:AB_145841){#interref0020}**Critical Commercial Assays**RNAqueous Micro Total RNA isolation kitAmbionCat\#AM1931SmartSeq2 V4 kitTakara ClontechCat\#634889Nextera XT library preparation kitIlluminaCat\#FC-131-1024Dynabeads Protein ALife TechnologiesCat\#10006DDynabeads Streptavidin M-280InvitrogenCat\#11206DMicropPlex Library Preparation kitDiagenodeCat\#05010012NextSeq ® 500/550 High Output Kit v2 (75 cycles)IlluminaCat\#FC-404-2005Nextera DNA kitIlluminaCat\#FC-121-1030NEB Next High-Fidelity 2X PCR Mas-ter MixNew England BiolabsCat\#M0543SLong Range HotStart PCR kitKAPA BiosystemsCat\#KK3501InFusion HD Cloning kitClontechCat\#638910DIG RNA Labelling KitRocheCat\#11277073910**Deposited Data**RNA-seq data (inc. single cell)This paperShinyApp GEO: [GSE106676](ncbi-geo:GSE106676){#intref0020}, Pagoda <https://github.com/tsslab/foxd3>ChIP-seq dataThis paperShinyApp GEO: [GSE106676](ncbi-geo:GSE106676){#intref0030}ATAC-seq dataThis paperShinyApp GEO: [GSE106676](ncbi-geo:GSE106676){#intref0035}**Experimental Models: Organisms/Strains**Zebrafish Gt(foxd3-citrine)^*ct*110^Sauka-Spengler laboratoryct110Zebrafish Gt(foxd3-mCherry)^*ct*110*R*^Sauka-Spengler laboratoryct110RTgBAC(foxd3-Avi-2A-Citrine)^*ox*161^Sauka-Spengler laboratoryox161Tg(ubiq:NLS-BirA-2A-Cherry)^*ox*114^Sauka-Spengler laboratoryox114**Recombinant DNA**BAC clone CH211-196F13CHORI <https://bacpacresources.org>CH211-196F13**Software and Algorithms**Sickle[@bib28]<https://github.com/najoshi/sickle>STAR 2.4.2a[@bib18]<https://github.com/alexdobin/STAR>FeatureCounts (v1.4.6-p4)[@bib44]<http://bioinf.wehi.edu.au/featureCounts>R v3.4.2R Core Team<https://www.r-project.org/>DESeq2 (v.1.14.1)[@bib95]<https://bioconductor.org/packages/release/bioc/html/DESeq2.html>edgeR[@bib65]<https://bioconductor.org/biocLite.R>SCDE[@bib20]<http://hms-dbmi.github.io/scde/index.html>PAGODA[@bib20]<http://hms-dbmi.github.io/scde/index.html>Bowtie (v.1.0.0)[@bib40]<http://bowtie-bio.sourceforge.net/bowtie2/index.html>Bedtools (v.2.15.0)[@bib40]<https://github.com/arq5x/bedtools>MACS2 (v2.1.0)[@bib92]<https://github.com/taoliu/MACS>HOMER (v.4.4)[@bib24]<http://homer.ucsd.edu/homer/index.html>SeqMINER[@bib89]<http://seqminer.genomic.codes>Deeptools (v.2.2.2)[@bib96]<https://github.com/deeptools/deepTools>MEME suite[@bib94]<http://meme-suite.org/doc/download.html>Gimmemotifs (v.0.9.0.3)[@bib79]<https://gimmemotifs.readthedocs.io/en/master/>GREAT[@bib50]<http://great.stanford.edu/public/html/>DiffBind[@bib73]<https://bioconductor.org/packages/release/bioc/html/DiffBind.html>

Contact for Reagent and Resource Sharing {#sec4.2}
----------------------------------------

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Tatjana Sauka-Spengler (<tatjana.sauka-spengler@imm.ox.ac.uk>).

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

For this study, both females and males of transgenic and wild-type zebrafish strains were used. Animals that were bred were from 3 months old to 2 years old. Zebrafish embryos that were used for the experiments were between 8-16 hours post fertilisation.

### Zebrafish Lines {#sec4.3.1}

Genetrap line, *Gt(foxd3-citrine)*^*ct110*^ was generated by ([@bib25]). Animals were handled in accordance to procedures authorized by the UK Home Office in accordance with UK law (Animals \[Scientific Procedures\] Act 1986) and the recommendations in the Guide for the Care and Use of Laboratory Animals. All vertebrate animal work was performed at the facilities of Oxford University Biomedical Services. Adult fish were maintained as described previously ([@bib84]). In brief, adult fish were exposed to 12 hour light -- 12 hour dark cycle (8am to 10pm light; 10pm to 8am dark), kept in a closed recirculating system water at 27-28.5°C, fed 3-4 times a day, kept at 5 fish per 1L density. Embryos were staged as described previously ([@bib34]). In brief, embryos were staged using a dissecting stereo-microscope. 75% epiboly stage was identified by observing a distinctively thicker dorsal side and visible epiblast, hypoblast and evacuation zone. 1-2ss -- by observing first/second segment furrow. 5-6ss -- counting 5/6 somites, apparent optical and Kupffer's vesicles and prominent polster. 14-16ss -- counting 14/16 somites, observing otic placode, v-shaped trunk somites.

Method Details {#sec4.4}
--------------

### Cell Dissociation and FAC-Sorting {#sec4.4.1}

Selected embryos were dissociated with collagenase (20mg/ml in 0.05% trypsin) at 30°C for 10-15mins with intermittent pipetting to achieve a single cell suspension. Cells were centrifuged at 500g for 10mins and re-suspended in Hanks buffer, passed through a 0.22μm filter and centrifuged at 750g for 10min, pelleted cells were re-suspended in ∼500μl Hanks buffer. Fluorescent positive cells were sorted and collected using BD FACS-Aria Fusion.

### Bulk RNA Extraction, Library Preparation and Sequencing {#sec4.4.2}

FACS sorted cells were washed with PBS and stored at 80°C in lysis buffer. RNA was extracted using Ambion RNAqueous Micro Total RNA isolation kit (AM1931), checked on Bioanalyser, samples with RIN\>7 were used to prepare cDNA using Takara Clontech SmartSeq2 V4 kit (634889). Sequencing libraries were prepared using Illumina Nextera XT library preparation kit (FC-131-1024). 75% Epiboly-stage cell libraries (Citrine-expressing, Citrine-Cherry-expressing and cells not expressing FoxD3) were sequenced using 80 bp reads using Illumina Nextseq500 platform. 5-6ss and 8ss cell libraries expressing FoxD3 (Citrine-expressing, Citrine-Cherry-expressing) were sequenced using 50bp paired-end (PE) reads on Illumina Hiseq2000 platform, and cells not expressing FoxD3 using 80bp PE reads on Illumina Nextseq500 platform. 12ss cell libraries expressing FoxD3 (Citrine-expressing, Citrine-Cherry-expressing) were sequenced using 100bp PE reads on Illumina Hiseq2000 platform. 14ss cell libraries (Citrine-expressing, Citrine-Cherry-expressing and cells not expressing FoxD3) were sequenced using 80bp PE reads using Illumina NextSeq500 platform.

### Single Cell RNA Preparation Library Preparation and Sequencing {#sec4.4.3}

Individual cells were collected by FACS, cDNA was generated and sequencing libraries were prepared as previously described ([@bib59]). Briefly, mRNAs were primed with oligo-dT and reverse transcribed using an LNA-containing template switching oligo. Libraries were generated from amplified cDNA by Tagmentation with Tn5. Libraries were sequenced using 50 bp single end reads for 96 cells. A 4 x10^7^ dilution of ERCC spike-in control was used.

### *In Situ* Hybridisation {#sec4.4.4}

In situ hybridisation was performed according to standard protocols, as described previously ([@bib25]). Probe synthesis was conducted with the components of the DIG RNA Labelling Kit (Roche). In brief, the digoxigenin RNA probes were of an average length of 100-200 nucleotides. Embryos were fixed 24 hours in 4% paraformaldehyde 1x PBS, manually dechorionated and dehydrated overnight in methanol at -20°C. Then the embryos were rehydrated back to 100% PBT (1x PBS, 0.1% Tween 20). Embryos were treated 10 minutes with proteinase K (10 mg/ml in PBT). The reaction was stopped by rinsing in glycine (2 mg/ml in PBT). Embryos were postfixed in 4% paraformaldehyde in 1x PBS for 20 minutes and then rinsed in PBT. The embryos were prehybridized at least 1 hour at 70°C in hybridization buffer. The hybridization was done in the same buffer containing 50 ng to 100 ng of probe overnight at 70°C. Embryos were washed and were incubated overnight at 4°C with the preabsorbed alkalinephosphatase-coupled anti-digoxigenin antiserum at a 1/5000 dilution in a PBT buffer containing 2 mg/ml BSA, 2% sheep serum. Embryos were washed 6 times for 15 minutes each in PBT at room temperature. Detection was performed in alkaline phosphatase reaction buffer, the reaction was stopped in 1x PBS.

### Generation of Avi-Tagged *foxd3* Transgenic Line {#sec4.4.5}

Tol2-mediated BAC transgenesis, as described in ([@bib78]), was used to generate *TgBAC(foxd3- Avi-2A-Citrine)*^*ox161*^ transgenic line. pGEM Avi-2A-Citrine-SV40pA-FRT-Kan-FRT recombination donor construct was generated by amplifying Avi-2A-Citrine cassette using Pfu polymerase (Pfu UltraII Hoststart PCR Master Mix, Agilent Technologies) and cloning it into the donor plasmid (\#89890, Addgene) using InFusion (InFusion HD Cloning kit, Clontech). The full donor cassette contains a FLAG epitope, a TEV protease recognition sequence, an in-frame 48bp Avi-Tag, a *Citrine* reporter followed by a polyA tail and a Kanamycin selection cassette flanked by flippase recognition target (FRT) sequences. *Citrine* reporter is separated from the *foxd3*-Avi gene by a viral linker, 2A, sequence that mediates ribosome skipping, thus allowing for co-expression of both components from a single transcript ([@bib33]). Genomic context of the *Danio rerio* BAC clone CH211-196F13 (203kb) was used for recombineering, as it harbours the full single exon ORF of the *foxd3* gene and the upstream regions (\>200kb), thus encompassing not only the *foxd3* promoter but also associated *cis*-regulatory elements. The *foxd3* gene within the BAC was fused to the Avi-tag producing C-terminally Avi-tagged foxd3 (foxd3-Avi-2A-Citrine) expressed in endogenous-like fashion. NLS-BirA zebrafish transgenic line *Tg(ubiq:NLS-BirA-2A-Cherry)*^*ox114*^ expresses 3xHA epitope, nuclear localisation signal (NLS) sequence fused to BirA, viral 2A sequence and a *Citrine* reporter gene under the control of ubiquitous *ubb* promoter.

### Foxd3 Biotin-ChIP, Library Preparation and Sequencing {#sec4.4.6}

Foxd3 Biotin-ChIP was performed on 700 for 75% epiboly, 350 for 1-2ss, 320 5-6ss experimental and BirA-only, 390 for 14ss whole embryos (∼128,000 cells of interest) were used for a corresponding stage foxd3 Biotin-ChIP. Embryos were manually dechorionated, cells were dissociated with 20 strokes using pestle A in isotonic nuclei extraction buffer (NEB: 0.5% NP40, 0.25% Triton X, 10 mM Tris-HCl (pH 7.5), 3 mM CaCl~2~, 0.25 M sucrose, 1mM DTT, 0.2 mM PMSF, 1X Proteinase inhibitor (PI) in a glass homogeniser and cross-linked using 1% formaldehyde at room temperature for 10 min. Fixation was quenched with 125 mM of glycine for 5min, cross-linker was washed-out by 3x pellet washes with 1x PBS (with 1X PI, 1 mM DTT and 0.2 mM PMSF) centrifuging at 2000g for 4min at 4°C. Pellets were re-suspended in NEB. Cell nuclei were expulsed with 20 strokes using pestle B in a glass homogeniser, pelleted and washed with 1 xPBS (with 1X PI, 1 mM DTT and 0.2 mM PMSF). Nuclei were lysed in SDS lysis buffer (0.7% SDS, 10mM EDTA, 50 mM Tris-HCl (pH 7.5), 1x PI). Cross-linked chromatin was sonicated at 12A, 10x (10s ON, 30s OFF) followed by 8A, 4x (30s ON, 30s OFF). Sheared chromatin samples were pre-cleared in pre-blocked Protein G beads (Dynabeads Protein G, Life Technologies) for 1 hour at 4°C. 1/20 of biotinChIP was collected as an input fraction and stored at -80°C. Pre-cleared chromatin samples were incubated on pre-blocked streptavidin beads (Dynabeads M-280 streptavidin beads, Invitrogen) o/n at 4°C. Beads were washed with SDS Wash Buffer (2% SDS, 10mM Tris-HCl (pH 7.5), 1 mM EDTA) at room temperature, followed by 4x RIPA washes (50 mM Hepes-KOH (pH 8.0), 500 mM LiCl, 1mM EDTA, 1% NP40, 0.7% Na-Deoxycholate, 1x PI) and 1x Na-Cl TE wash (1x TE, 50mM NaCl) at 4°C. Chromatin was eluted from the beads with SDS ChIP elution buffer (50 mM Tris-HCl (pH 7.5), 10 mM EDTA, 1% SDS). Cross-linking was reversed o/n at 70°C in the thermomixer at 1300 rpm. Cellular RNA was digested with RNaseA (0.2 μg/ml) at 37°C for 1 hour, and cellular proteins were removed with Proteinase K (0.4 mg/ml) at 55°C for 2 hours. Chromatin samples were separated from the streptavidin beads and input and ChIP DNA was extracted using a standard phenol-chloroform extraction method. Libraries were prepared using MicropPlex Library Preparation v1 or v2 kit (Diagenode) (75% epiboly - 13 cycles, 1-2ss - 12 cycles, 5-6ss - 12 cycles, BirA-only - 10 cycles, 14ss - 10 cycles of amplification) and sequenced using NextSeq® 500/550 High Output Kit v2 (75 cycles) on NextSeq500 sequencing platform.

### ATAC, Library Preparation and Sequencing {#sec4.4.7}

FACS sorted cells were lysed (10mM Tris-HCl, pH7.4, 10mM NaCl, 3mM MgCl2, 0.1% Igepal) and tagmented using Nextera DNA kit (Illumina FC-121-1030) for 30mins at 37°C. Tagmented DNA was amplified using NEB Next High-Fidelity 2X PCR Master Mix for 11 cycles. Tagmentation efficiency was assessed using Agilent Tapestation. ATAC-Rx was carried out per ATAC protocol described above with the addition of 50% extra Drosophila S2 cells as reference chromatin (Orlando et al., 2014). ATAC-seq libraries were sequenced using 40 bp PE run on Illumina NextSeq500 platform.

### H3K27Ac ChIP, Library Preparation and Sequencing {#sec4.4.8}

FACS sorted cells were cross-linked with 1% formaldehyde. Fixation was quenched with 125 mM of glycine for 5min. Cross-linker was washed-out by 3x pellet washes with 1x PBS (with 1X PI, 1 mM DTT and 0.2 mM PMSF) centrifuging at 2000g for 4min at 4°C. Pellets were re-suspended in isotonic nuclei extraction buffer (NEB: 0.5% NP40, 0.25% Triton X, 10 mM Tris-HCl-pH 7.5, 3 mM CaCl~2~, 0.25 M sucrose, 1mM DTT, 0.2 mM PMSF, 1X Proteinase inhibitors (PIs). Cell nuclei were expulsed with 20 strokes using pestle B in a glass homogeniser, pelleted and washed with 1 xPBS (with 1X PI, 1 mM DTT and 0.2 mM PMSF). Nuclei were lysed in SDS lysis buffer (0.7% SDS, 10mM EDTA, 50 mM Tris-HCl (pH 7.5), 1x PI). Cross-linked chromatin was sonicated at 12A, 10x (10s ON 30s OFF) followed by 8A, 4x (30s ON 30s OFF) and sonicated into 300-800bp fragments. Pre-blocked Protein A Dynabeads were pre-incubated with antibody (Abcam Ab4729) and sonicated DNA-protein complexes were applied to beads o/n at 4°C, IgG antibody (Millipore 12-370) was used as control and an input sample was taken. Samples were washed 6x with RIPA buffer (50 mM Hepes-KOH (pH 8.0), 500 mM LiCl, 1mM EDTA, 1% NP40, 0.7% Na-Deoxycholate, 1x PIs) and 1x NaCl TE wash (1x TE, 50mM NaCl) at 4°C. Chromatin was eluted from the beads with SDS ChIP elution buffer (50 mM Tris-HCl (pH 7.5), 10 mM EDTA, 1% SDS). Cross-linking was reversed o/n at 70°C in the thermomixer at 1300 rpm. Cellular RNA was digested with RNaseA (0.2 μg/ml) at 37°C for 1 hour, and cellular proteins were removed with Proteinase K (0.4 mg/ml) at 55°C for 2 hours. Samples were purified by standard phenol-chloroform extraction and ethanol precipitation. Libraries were prepared using NEBNext® Ultra DNA^*T\ M*^ library prep kit according to manufacturer's instructions. Libraries were amplified using ([@bib3]) protocol for small-cell-number ChIP. H3K27Ac ChIP libraries were sequenced using 50bp PE reads using Illumina Hiseq2500 platform.

### Enhancer Reporter Constructs {#sec4.4.9}

All enhancer inserts were generated by PCR using KAPA Long Range HotStart PCR kit (Kapa Biosystems) and cloned into the E1b:GFP:Ac/Ds vector using the InFusion kit (InFusion HD Cloning kit, Clontech). Fertilised single-cell embryos were injected with 30pg of plasmid DNA and 25pg of Ac mRNA. Injected embryos were imaged on a Zeiss780 LSM inverted confocal microscope equipped with EC Plan-Neofluar 10x/0.30 NA WD=5.2 (Zeiss) objective or using a Zeiss Axio Scope.A1 equipped with 5x/0.15 NA N-Achroplan or 10x/0.3 NA EC Plan-Neofluar objectives (Zeiss) at desired developmental stages.

### Foxd3 Ectopic Expression Assay {#sec4.4.10}

40pg of foxd3 mRNA was injected into single cell stage heterozygous *Gt(foxd3-mCherry)*^*ct110*^ embryos. Whole embryos were collected at 50% epiboly for FACS analysis as described above. For the *foxd3* overexpression followed by ATAC-seq experiments 40pg of *foxd3* mRNA was injected into single cell wild-type fertilised embryos. 50% epiboly embryos were dissected to obtain cells that do not express foxd3 intrinsically: 12,000 cells were used per each experimental/control sample in triplicates. Cells were dissociated with 0.05% trypsin to a single cell suspension, centrifuged and re-suspended in Hanks buffer. Cells were lysed as above and tagmented using Nextera DNA kit (Illumina FC-121-1030) for 15 minutes at 37°C, reactions were quenched with 50mM EDTA for 30 minutes at 50°C. Tagmented DNA was amplified using NEB Next High-Fidelity 2X PCR Master Mix for 15 cycles. Tagmentation efficiency was assessed using Agilent Tapestation and libraries were sequenced using 40bp PE sequencing on Illumina NextSeq500 platform.

### Bioinformatic Processing {#sec4.4.11}

#### Bulk RNA-Seq Processing {#sec4.4.11.1}

Reads were trimmed to remove low quality bases using sickle ([@bib28]) when necessary. Read quality was evaluated using FastQC (Barbaraham). Mapping to GRCz10/danRer10 assembly of the zebrafish genome downloaded from UCSC Genome Browser was performed using STAR2.4.2a.(2) ([@bib18]). Read counts were obtained using subread FeatureCounts(v1.4.6-p4) ([@bib44]) using standard parameters using a gene model gtf derived from Ensembl annotation downloaded from UCSC genome browser. Gene model for ENSDARG00000095311 (the antisense transcript of FoxD3), was removed from gene models. Differential Expression analysis was carried out using in DESeq2 (v.1.14.1) or (v.1.18.1).

#### Analysis of Single-Cell RNA Sequencing {#sec4.4.11.2}

Short reads (51bp) from 96 cells were aligned to the zebrafish genome (GRCz10/danRer10 assembly) and ERCC spike-in controls using STAR ([@bib18]) with default parameters. The featureCounts ([@bib44]) was then used to count the number of mapped reads to the reference gene models. Expression values were quantified as read per kilobase of transcript length per million of mapped reads (RPKM) on the basis of Ensembl gene annotation using the "rpkm" function in edgeR ([@bib65]). We used cells with higher than 100,000 mapping reads and 2,000 detected genes (RPKM\>1) for the downstream analysis. With these cut-off criteria, one cell was excluded due to the low sequencing depth. We performed the principal component analysis (PCA) using the custom R script. We selected top 500 genes with the highest absolute correlation coefficient (PCA component loadings) in one of the first three components and then performed PCA and T-distributed stochastic neighbour embedding (tSNE) analyses. The heatmap was visualised on selected gene sets based on the log~2~ of RPKM scale using the "pheatmap" function in R. For purpose of single cell transcriptional cataloguing, the scRNA-seq data is visualised using SCDE package (<http://hms-dbmi.github.io/scde/index.html>) ([@bib20]). Additional analysis was carried out using PAGODA R package ([@bib20]). 50% epiboly demultiplexed scRNASeq data was kindly provided by R.Satija ([@bib66]), and processed as described above. Only *foxd3*-expressing cells from 50% epiboly scRNA-seq dataset were used in analysis.

#### *De Novo* Transcriptome Assembly {#sec4.4.11.3}

Trinity (v.2.3.2) was run with default parameters on RNA-seq reads from 5-6ss Citrine and 5-6ss Citrine-Cherry after read trimming. FoxD3 ORF truncation was ascertained using blast for a full *foxd3* sequence.

### ATAC-Seq Processing {#sec4.4.12}

Reads were trimmed for quality using sickle when necessary and mapped using Bowtie (v.1.0.0) ([@bib40]). Bigwig files were generated using an enhanced Perl script courtesy of Jim Hughes. Peak calling was performed as described previously ([@bib11]). Briefly, BAM files were sorted by name and paired end bed files were obtained using bedtools (v.2.15.0) bamtobed -bedpe. Reads that were not properly paired were discarded and paired reads were displaced by +4 bp and -5 bp. Reads were extended to a read length of 100bp. Peak calling was performed using MACS2 callpeak -f BED -shiftsize=100 -nomodel -slocal 1000 parameters ([@bib92]). To obtain mappable data, a synthetic 40bp-long single end fastq dataset was generated and mapped using bowtie (v.1.0.0) using --m 1 parameter. Bedgraph files were obtained using bedtools genomeCoverageBed -bg -split function.

MACS2-called peaks that overlapped with regions which in the mappable did not correspond to read size (40bp) were discarded. Identification of peaks corresponding to TSS/promoter, intergenic, intronic and TES locations was carried out using Homer (v.4.8) ([@bib24]) annotatePeaks.pl script. Only peaks present in both replicates were retained, using bedtools to intersect function to generate reference ATAC-seq ensembles for each stage. ATAC-Rx-seq was processed similarly with the exception that a combined genome of containing danRer10 and Drosophila melanogaster dm6 genomes was created and all reads were mapped to the latter. Zebrafish read counts were normalised as described previously ([@bib58]). K-means clustering of ATAC-seq signal was carried out using SeqMINER software as described ([@bib89]). In brief, we used non-promoter ATAC-seq peaks form 5-6ss samples as reference points for clustering using following settings: no auto-turning, wiggle step - 15, k-means enrichment linear clustering to cluster given loci presenting similar read densities within the specified window (1500bp on each side of the reference coordinate). Nucleosome localisation was carried out using nucleoATAC suite using default parameters in peaks called at each stage. Bedtools was used to generate bigwig files and clustering of nucleoATAC bigwig signal was carried out using deepTools (v.2.2.2) using k-means clustering with 20 clusters.

For the foxd3 over-expression followed by ATAC-seq: Reads were processed as above. Duplicated reads were removed using MarkDuplicates (picard-tools/1.83). All samples were randomly down-sampled to the lowest-read containing sample (10,443,726) using samtools-1.1. Processed experimental BAM files were merged together as well as control BAM files. *K*-means clustering of ATAC-seq signal was carried out using SeqMINR software as described above ([@bib89]), using 3.1 enhancer cluster ATAC-seq peaks and all pulled foxd3 Biotin-ChIP peaks as references for clustering. Averaged ATAC signal plots were generated using deepTools (v.2.2.2) on the selected *k*-means clusters.

### H3K27Ac-ChIP Processing {#sec4.4.13}

Reads were trimmed for quality using sickle when necessary and mapped using bowtie (v.1.0.0). Bigwig files were generated using an enhanced Perl script courtesy of Jim Hughes. MACS2 was used to identify peaks using standard parameters. Only peaks present in both replicates were retained, using bedtools intersect function. *k*-means clustering of H3K27Ac signal was carried out using SeqMINER software as described ([@bib89]).

### Foxd3 Biotin-ChIP Processing {#sec4.4.14}

Foxd3 Biotin-ChIP Processing Reads were trimmed for quality using sickle when necessary and mapped using bowtie (v.1.0.0). Duplicates were removed using MarkDuplicates (picard-tools/1.83). Input reads were normalised to the same number of ChIP reads by random down-sampling using samtools-1.1 (BirA - 18,545,346, 75% epiboly - 28,663,648, 1-2ss - 15,989,800, 5-6ss - 24,270,738, 14ss - 32,322,010 unique reads). Bigwig files were generated using an enhanced Perl script courtesy of Jim Hughes. Peak calling was performed using Homer (v.4.7) ([@bib24]) findPeaks script using -size 200-minDist 1500 parameters. Peaks were annotated to a nearest expressed gene at a given developmental stage in NC cell population. GO analysis was performed on acquired gene lists in [pantherdb.org](http://pantherdb.org){#intref0145} using statistical overrepresentation binomial test for complete biological processes. Motif discovery and characterisation was performed using Homer screening for *de novo* motifs within given foxd3 Biotin-ChIP-seq peaks. Significantly enriched motifs were annotated manually based on Homer results and levels of gene expression in NC at a corresponding developmental stage. All possible combinations of two motifs were computed using a custom R (v. 3.2.1) script. Homer/4.7 annotatePeaks.pl script was utilised to screen all *de novo* motifs in foxd3 Biotin-ChIP-seq peaks co-occurring in windows of 500bp centred around peaks. A custom Python3 script using the Pandas package (courtesy of Ivan Candido-Ferreira) was used to calculate the frequency of 2-way motif combinations within foxd3-bound ChIP peaks. Combinations enriched at *χ*2 P\< 5 x 10^*−*3^ with FDR correction for multiple hypothesis (vs testing co-motif enrichment frequencies against random DNA sequence background) were retained. Two-way networks were plotted using the 'Circlize' package in R.

### Transcription Factor Binding Site Identification on ATAC-Seq Peaks {#sec4.4.15}

Initial Transcription Factor Binding Site (TFBS) enrichment analysis of known motifs was performed using Homer suite (findMotifsGenome.pl) ([@bib24]). The analysis was performed for all *k*-means clusters, using the default 200bp window centred on the ATAC-peak, and all non-promoter putative regions were used as background. Due to paucity of available zebrafish transcription factor binding sites (TFBS), a clustering approach of known transcription factors sites was utilized. TFBS for each gene family of interest were downloaded from CIS-BP (<http://cisbp.ccbr.utoronto.ca>) ([@bib83]). Binding sites were clustered using gimme suite's cluster option (v. 0.9.0.3) ([@bib79]). Background values for each of the clustered motifs were obtained using gimme background function. Cutoff values relative to background sequences were obtained using gimme threshold function. Binding sites were identified using gimme scan function using threshold values obtained from previous step in peaks obtained form ATAC-seq processing.

### *K*-Means Clustering {#sec4.4.16}

*K*-means clustering was performed using the R platform ([@bib89]), by applying the linear enrichment clustering approach to the normalised ATAC-seq datasets and computing the accessibility signal over the non-promoter peaks (+/- 1.5 kb from the centre) using the ensemble of peaks containing both elements common all C replicates, as well as elements common to all CC replicates as a reference. Differences in chromatin accessibility for different *k*-means clusters were quantified by plotting the normalised C and CC ATAC-seq counts for all of putative regulatory elements in cluster and calculating Pearson correlation coefficients. *K*-means clustering investigating dynamics of chromatin opening at the NC *cis*-regulatory elements was performed on 75% epiboly and bud stage ATAC-seq datasets, using called 5-6ss non-promoter ATAC peaks as a reference. Functional annotation of each *k*-means cluster was performed using the GREAT Tool ([@bib50]), using whole genome as background. GREAT employs annotations of putative *cis*-regulatory elements to nearby genes and their statistical integration to infer their function. Statistical significance of associated terms was calculated using binomial and hypergeometric tests and either Bonferroni of False Discovery Rate correction.

### Differential Chromatin Accessibility Analysis {#sec4.4.17}

The differential chromatin accessibility analysis of ATAC-seq dataset in foxd3-mutant and control conditions was performed using DiffBind package for differential binding analysis of ChIP-seq ([@bib73]). Related plots were generated in R. Significantly differentially accessible peaks were identified using the edgeR package, using a reference ATAC-seq peak ensemble. Benjamini--Hochberg multiple testing correction of the resulting p-values was used to derive false discovery rates (FDRs) and only differentially accessible elements with an FDR\<0.1 were taken in account.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

Statistical details of experiments can be found in the figure legends, including p-values and FDR cutoffs. Specific p-values are given in the text where appropriate. Sequencing data, significant differences were defined as an adjusted *p*-value\<0.05, unless otherwise noted in the appropriate [Method Details](#sec4.4){ref-type="sec"} sub-section. Statistical analyses were performed in Microsoft Excel or R.

Data and Software Availability {#sec4.6}
------------------------------

The beta version of the ShinyApp associated with the data produced in this study and Pagoda App ([@bib20]) presenting single cell catalogues can be downloaded from <https://github.com/tsslab/foxd3>. The live app can be accessed here: <https://livedataoxford.shinyapps.io/FoxD3-project-TSS-Lab/>. The accession number for the sequencing data generated and reported in this paper is \[GEO: [GSE106676](ncbi-geo:GSE106676){#intref0165}\].
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